https://curecurrent.com/trials/a-single-dose-of-pembrolizumab-in-hiv-infected-people-127008https://curecurrent.com/trials/improving-hiv-prevention-among-adolescent-girls-and-young-women-agyw-in-uganda-127009https://curecurrent.com/trials/long-acting-injectable-antiretroviral-treatment-to-improve-hiv-treatment-among-justice-involved-persons-being-released-t-127010https://curecurrent.com/trials/arvs-to-prevent-breastmilk-hiv-viral-and-immune-responses-127011https://curecurrent.com/trials/improving-treatment-and-retention-adherence-in-nontraditional-settings-127012https://curecurrent.com/trials/tailored-motivational-interviewing-implementation-effectiveness-trial-in-multidisciplinary-adolescent-hiv-care-settings-127013https://curecurrent.com/trials/phase-4-comparative-trial-of-benzathine-penicillin-g-for-treatment-of-early-syphilis-in-subjects-with-or-without-hiv-inf-127014https://curecurrent.com/trials/fixed-dose-combination-of-bictegravir-emtricitabine-tenofovir-alafenamide-taken-as-5-days-per-week-127015https://curecurrent.com/trials/drinkers-intervention-to-prevent-tuberculosis-dipt-study-127016https://curecurrent.com/trials/pharmacokinetics-of-antiretroviral-agents-in-hiv-infected-pregnant-women-127017https://curecurrent.com/trials/tolerability-of-lopinavir-versus-dolutegravir-for-children-and-adolescents-living-with-hiv-127018https://curecurrent.com/trials/adipose-tissue-after-switch-to-doravirine-127019https://curecurrent.com/trials/switch-from-etravirine-to-doravirine-as-a-part-of-antiretroviral-combination-127020https://curecurrent.com/trials/evolution-of-the-clinical-immuno-virological-and-aging-trajectory-of-patients-living-with-hiv-127021https://curecurrent.com/trials/hiv-1-infected-patients-phase-ii-trial-dual-combination-doravirine-raltegravir-open-label-127022https://curecurrent.com/trials/headstart-evaluating-the-effectiveness-of-community-art-delivery-for-people-newly-diagnosed-with-hiv-127023https://curecurrent.com/trials/computer-based-intervention-for-alcohol-using-hiv-hcv-women-127024https://curecurrent.com/trials/body-composition-sub-study-of-the-d2eft-trial-127025https://curecurrent.com/trials/neuroinflammation-and-modulating-factors-in-depression-and-hiv-127026https://curecurrent.com/trials/nc-young-women-s-coop-127027https://curecurrent.com/trials/implementation-of-onsite-rapid-art-initiation-among-people-who-inject-drugs-living-with-hiv-at-syringe-services-program-127028https://curecurrent.com/trials/adapting-an-adolescent-friendly-prep-program-for-uasin-gishu-county-kenya-127029https://curecurrent.com/trials/treating-south-african-pregnant-women-for-methamphetamine-127030https://curecurrent.com/trials/implementation-research-for-vulnerable-women-in-south-africa-127031https://curecurrent.com/trials/whc-women-s-health-coop-plus-127032https://curecurrent.com/trials/the-prepare-project-prevention-empowering-and-protecting-young-women-in-south-africa-127033https://curecurrent.com/trials/young-women-s-coop-study-127034https://curecurrent.com/trials/young-women-s-health-coop-cooperative-in-cape-town-127035https://curecurrent.com/trials/cape-town-young-women-s-health-coop-127036https://curecurrent.com/trials/prepare-prep-in-pregnancy-accelerating-reach-and-efficiency-127037https://curecurrent.com/trials/persistence-of-neutralizing-antibodies-against-yellow-fever-yf-in-hiv-infected-patients-127038https://curecurrent.com/trials/using-electronic-medical-record-data-to-improve-hiv-primary-care-127039https://curecurrent.com/trials/impact-of-mediterranean-diet-in-cardiovascular-risk-among-people-with-hiv-127040https://curecurrent.com/trials/cord-blood-transplant-with-dilanubicel-for-the-treatment-of-hiv-positive-hematologic-cancers-127041https://curecurrent.com/trials/lactoferrin-treatment-in-hiv-patients-127042https://curecurrent.com/trials/anti-sars-cov-2-seroconversio-in-immune-mediated-kidney-diseases-127043https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-adherence-intervention-for-women-with-substance-use-disorders-127044https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-uptake-and-adherence-intervention-for-women-with-trauma-related-conditions-127045https://curecurrent.com/trials/early-anti-retroviral-treatment-in-hiv-infected-children-127046https://curecurrent.com/trials/survey-of-procedures-and-resources-for-initiating-treatment-of-hiv-in-africa-zambia-127047https://curecurrent.com/trials/doravirine-islatravir-dor-isl-in-heavily-treatment-experienced-hte-participants-for-human-immunodeficiency-virus-type-1-127048https://curecurrent.com/trials/survey-of-procedures-and-resources-for-initiating-treatment-of-hiv-in-africa-south-africa-127049https://curecurrent.com/trials/survey-of-procedures-and-resources-for-initiating-treatment-of-hiv-in-africa-malawi-127050https://curecurrent.com/trials/phase-ii-trial-of-art-dual-bnabs-vs-art-placebo-during-primary-hiv-1-infection-impact-on-post-art-control-127051https://curecurrent.com/trials/defining-the-potency-of-dtg-3tc-for-suppressed-hiv-patients-in-real-life-the-dualing-study-127053https://curecurrent.com/trials/electronic-cigarettes-as-a-harm-reduction-strategy-among-people-living-with-hiv-aids-127054https://curecurrent.com/trials/sti-hiv-intervention-behavioral-intervention-program-127055https://curecurrent.com/trials/bone-health-in-aging-hiv-infected-women-127056https://curecurrent.com/trials/how-does-antiretroviral-therapy-affect-coronary-atherosclerosis-a-serial-ct-study-127057https://curecurrent.com/trials/reducing-the-burden-of-malaria-in-hiv-uninfected-pregnant-women-and-infants-127058https://curecurrent.com/trials/dose-escalation-trial-of-cd40-hivri-env-vaccine-combined-or-not-with-a-dna-hiv-pt123-hiv-1-vaccine-in-healthy-volunteers-127059https://curecurrent.com/trials/nola-gem-feasibility-and-acceptability-of-an-mhealth-intervention-for-violence-affected-plwh-127060https://curecurrent.com/trials/differentiated-service-delivery-dsd-for-people-living-with-hiv-plhiv-and-comorbidities-127061https://curecurrent.com/trials/characterization-of-acute-and-recent-hiv-1-infections-in-zurich-127062https://curecurrent.com/trials/crowdsourcing-to-reduce-hiv-stigma-among-adolescents-and-young-adults-in-kazakhstan-127063https://curecurrent.com/trials/dhfs-for-medication-adherence-support-during-hospital-admissions-for-person-living-with-hiv-127064https://curecurrent.com/trials/host-blood-rna-signatures-for-diagnosis-of-tb-127065https://curecurrent.com/trials/evaluating-the-safety-tolerability-pharmacokinetics-and-antiviral-activity-of-the-monoclonal-antibody-pgt121-414-ls-admi-127066https://curecurrent.com/trials/biomarkers-to-predict-time-to-plasma-hiv-rna-rebound-127067https://curecurrent.com/trials/e-health-for-zero-infections-facilitating-access-to-and-use-of-hiv-pre-exposure-prophylaxis-prep-in-the-netherlands-127068https://curecurrent.com/trials/promoting-csd500-use-among-women-in-established-relationships-127069https://curecurrent.com/trials/adherence-interventions-for-hiv-youth-via-text-cell-phone-sequential-multiple-assignment-randomized-trial-smart-127070https://curecurrent.com/trials/quit-for-life-qfl-smoking-cessation-among-chinese-smokers-living-with-hiv-127071https://curecurrent.com/trials/safety-of-and-immune-response-to-dolutegravir-in-hiv-1-infected-infants-children-and-adolescents-127072https://curecurrent.com/trials/connecting-resources-for-urban-sexual-health-127073https://curecurrent.com/trials/ending-transmission-of-hiv-hcv-and-stds-and-overdose-in-rural-communities-of-people-who-inject-drugs-ethic-127074https://curecurrent.com/trials/tobacco-cessation-tailored-to-patients-living-with-hiv-plwh-in-brazil-127075https://curecurrent.com/trials/occult-hepatitis-b-virus-infection-and-hbv-reactivation-after-switching-to-long-acting-therapy-in-patients-with-hiv-1-127076https://curecurrent.com/trials/hiv-related-stigma-intervention-for-malaysian-clinicians-127077https://curecurrent.com/trials/the-effect-of-biktarvy-b-f-taf-on-whole-body-insulin-sensitivity-lipid-and-endocrine-profile-in-healthy-volunteers-127078https://curecurrent.com/trials/a-study-to-investigate-the-potential-drug-drug-interaction-between-vh4524184-and-oral-contraceptive-loestrin-in-healthy-127079https://curecurrent.com/trials/screening-for-hpv-and-cervical-cancer-in-young-women-with-perinatally-acquired-hiv-127080https://curecurrent.com/trials/to-reach-unrestricted-services-for-transgender-women-127081https://curecurrent.com/trials/patient-actor-training-to-improve-hiv-services-for-adolescents-in-kenya-127082https://curecurrent.com/trials/economic-navigation-and-strengthening-to-research-unrestricted-services-for-transgender-women-entrust-127083https://curecurrent.com/trials/tajik-migrant-health-education-study-127084https://curecurrent.com/trials/hiv-prevention-intervention-for-latino-male-couples-127085https://curecurrent.com/trials/strengthening-evidence-on-optimal-multidrug-resistant-tuberculosis-treatment-regimens-127086https://curecurrent.com/trials/instacare-rapid-art-initiation-among-persons-with-hiv-and-out-of-care-127087https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-recombinant-hiv-1-envelope-protein-bg505-sosip-gt1-1-gp140-127088https://curecurrent.com/trials/variation-in-drug-interactions-in-people-with-hiv-plwh-aged-60-years-and-older-127089https://curecurrent.com/trials/b-free-multistage-trial-127090https://curecurrent.com/trials/drug-drug-interaction-study-of-vesatolimod-in-adults-with-hiv-1-who-have-very-low-or-undetectable-virus-levels-127091https://curecurrent.com/trials/pertussis-immunization-during-pregnancy-hiv-infection-127092https://curecurrent.com/trials/safety-tolerability-and-acceptability-of-long-acting-cabotegravir-cab-la-for-the-prevention-of-hiv-among-adolescent-fema-127093https://curecurrent.com/trials/study-of-ebt-101-in-aviremic-hiv-1-infected-adults-on-stable-art-127094https://curecurrent.com/trials/addressing-drug-use-stigma-in-human-immunodeficiency-virus-hiv-care-and-treatment-clinics-in-tanzania-127095https://curecurrent.com/trials/approach-2-0-hiv-hcv-and-syphilis-testing-through-pharmacies-127096https://curecurrent.com/trials/a-clinical-phase-3-trial-of-vla1553-in-adult-participants-with-human-immunodeficiency-virus-hiv-127097https://curecurrent.com/trials/filling-gaps-in-the-hiv-pre-exposure-prophylaxis-cascade-through-counseling-127098https://curecurrent.com/trials/immunocompetent-versus-immunocompromised-tuberculosis-tb-patients-127099https://curecurrent.com/trials/a-global-registry-on-second-generation-and-long-acting-integrase-inhibitor-failures-127100https://curecurrent.com/trials/data-informed-stepped-care-disc-to-improve-adolescent-hiv-outcomes-uh3-127101https://curecurrent.com/trials/improving-health-outcomes-in-young-cisgender-men-and-transgender-women-mlab-app-127102https://curecurrent.com/trials/hiv-self-testing-and-uptake-and-retention-of-prep-among-older-adolescent-msm-and-tgw-127103https://curecurrent.com/trials/study-to-assess-the-effects-of-cabotegravir-cab-and-rilpivirine-rpv-long-acting-la-injections-following-sub-cutaneous-sc-127104https://curecurrent.com/trials/same-day-antiretroviral-therapy-initiation-127105https://curecurrent.com/trials/study-to-evaluate-safety-tolerance-and-efficacy-of-asc22-combined-with-art-in-subjects-with-hiv-127106https://curecurrent.com/trials/study-to-evaluate-the-feasibility-of-integrating-the-point-of-care-testing-for-sexually-transmitted-infections-and-hiv-i-127107https://curecurrent.com/trials/anal-hpv-infection-and-risk-for-anal-high-grade-squamous-intraepithelial-lesion-among-thai-msm-with-acute-hiv-infection-127108https://curecurrent.com/trials/evaluation-of-prep-30-a-demonstration-project-of-pre-exposure-prophylaxis-for-msm-and-other-high-risk-group-clients-at-t-127109https://curecurrent.com/trials/differentiated-service-delivery-for-antiretroviral-therapy-127110https://curecurrent.com/trials/exploration-of-the-neo-vagina-study-127111https://curecurrent.com/trials/client-and-provider-preferences-for-hiv-care-127112https://curecurrent.com/trials/assessment-of-drug-drug-interactions-between-feminizing-hormone-therapy-and-emtricitabine-tenofovir-alafenamide-concomit-127113https://curecurrent.com/trials/assessment-of-drug-drug-interactions-between-masculinizing-hormone-therapy-and-antiretroviral-agents-concomitantly-for-p-127114https://curecurrent.com/trials/trends-of-morbidity-and-mortality-among-thai-hiv-infected-and-hiv-uninfected-patients-a-five-year-prospective-cohort-stu-127115https://curecurrent.com/trials/innovative-strategy-to-offer-online-test-and-treat-for-thai-msm-tg-127116https://curecurrent.com/trials/utech-machine-learning-for-hiv-prevention-among-substance-using-gbmsm-127117https://curecurrent.com/trials/adequacy-of-the-new-pediatric-isoniazid-rifampin-pyrazinamide-hrz-tablet-127118https://curecurrent.com/trials/thai-msm-tg-test-and-treat-study-127119https://curecurrent.com/trials/multiple-family-group-intervention-programming-to-improve-mental-health-of-adolescents-living-with-hiv-in-ghana-an-imple-127120https://curecurrent.com/trials/leveraging-mhealth-and-peers-to-engage-african-americans-and-latinxs-in-hiv-care-lean-127121https://curecurrent.com/trials/reducing-hiv-related-stigma-in-school-children-in-northern-uganda-127122https://curecurrent.com/trials/scientific-evaluation-of-peer-education-and-std-treatment-to-reduce-the-spread-of-hiv-in-zimbabwe-127123https://curecurrent.com/trials/evaluating-the-impact-of-online-educator-microskill-training-on-educator-knowledge-and-skill-127124https://curecurrent.com/trials/safety-and-efficacy-of-a-switch-to-doravirine-tenofovir-lamivudine-mk-1439a-in-human-immunodeficiency-virus-hiv-1-infect-127125https://curecurrent.com/trials/comparison-of-doravirine-tenofovir-lamivudine-mk-1439a-and-atripla-in-treatment-naive-human-immunodeficiency-virus-type-127126https://curecurrent.com/trials/camu-camu-in-art-treated-people-living-with-hiv-127127https://curecurrent.com/trials/a-phase-i-study-of-quadrivalent-human-papilloma-virus-hpv-types-6-11-16-18-recombinant-vaccine-in-hiv-infected-and-hiv-n-127128https://curecurrent.com/trials/protease-inhibitor-vs-raltegravir-based-art-and-inflammation-in-hiv-infection-127129https://curecurrent.com/trials/caspofungin-for-pneumocystis-pneumonia-in-plwhiv-127130https://curecurrent.com/trials/increasing-neonatal-hiv-test-and-treat-to-maximize-the-long-term-impact-on-infant-health-and-novel-infant-antiretroviral-127131https://curecurrent.com/trials/maternal-depression-treatment-in-hiv-127132https://curecurrent.com/trials/evaluation-of-3t-a-sex-positive-hiv-sti-mobile-app-intervention-for-young-black-men-ages-14-19-attracted-to-men-127133https://curecurrent.com/trials/t-cell-responses-to-concurrent-hiv-and-herpesvirus-infections-127134https://curecurrent.com/trials/a-pragmatic-trial-to-expand-youth-friendly-hiv-self-testing-127135https://curecurrent.com/trials/switch-from-oral-therapy-to-long-acting-injectable-cabotegravir-rilpivirine-127136https://curecurrent.com/trials/development-and-pilot-testing-of-the-sense2quit-app-127137https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-codivir-in-addition-to-standard-antiretroviral-treatment-for-hiv-i-127138https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-tolerability-and-immunogenicity-of-16055-nfl-delta-gly4-env-protein-trimer-and-tri-127139https://curecurrent.com/trials/hiv-and-multi-drug-resistant-tuberculosis-a-study-on-clinical-outcomes-127140https://curecurrent.com/trials/tolerance-and-effectiveness-of-c14-on-hpv-infection-127141https://curecurrent.com/trials/improving-hiv-testing-linkage-and-retention-in-care-for-men-through-u-u-messaging-127142https://curecurrent.com/trials/zambia-infant-cohort-study-brains-optimized-for-surviving-and-thriving-127143https://curecurrent.com/trials/hope-social-media-intervention-for-hiv-testing-and-studying-social-networks-127144https://curecurrent.com/trials/topical-curcumin-for-precancer-cervical-lesions-127145https://curecurrent.com/trials/contraceptive-hormones-immunity-and-microbiome-evaluation-127146https://curecurrent.com/trials/a-study-to-determine-the-safety-and-efficacy-of-rilpivirine-in-treatment-naive-indian-participants-with-human-immunodefi-127147https://curecurrent.com/trials/prepare-a5361s-ancillary-study-of-reprieve-a5332-127148https://curecurrent.com/trials/primary-and-secondary-drug-resistance-mutations-drms-in-hiv-as-a-risk-factor-of-failure-of-art-including-two-drugs-based-127149https://curecurrent.com/trials/cohort-imea-070-lenacapavir-compassional-127150https://curecurrent.com/trials/the-impact-of-online-educator-mircoskill-training-and-parent-microskill-training-on-student-sexual-health-related-outcom-127151https://curecurrent.com/trials/imaging-immune-activation-in-hiv-by-pet-mr-127152https://curecurrent.com/trials/collision-of-three-global-pandemics-the-effect-of-tuberculosis-and-hiv-on-the-epidemiological-clinical-virological-and-i-127153https://curecurrent.com/trials/antimalarial-pharmacology-in-children-and-pregnant-women-in-uganda-127154https://curecurrent.com/trials/strategic-antiretroviral-therapy-and-hiv-testing-for-youth-in-rural-africa-127155https://curecurrent.com/trials/evaluation-of-pre-exposure-prophylaxis-prep-in-pregnant-and-breastfeeding-women-127156https://curecurrent.com/trials/gene-expression-outcomes-in-interventions-for-substance-using-hiv-minority-men-127157https://curecurrent.com/trials/using-open-contest-and-neuro-influence-experiment-to-develop-and-evaluate-prep-promotion-messages-for-high-risk-men-127158https://curecurrent.com/trials/an-adaptive-intervention-for-depression-among-latinos-living-with-hiv-127159https://curecurrent.com/trials/safety-and-tolerability-study-of-op-724-in-liver-cirrhosis-patients-by-hiv-hcv-with-hemophilia-127160https://curecurrent.com/trials/electronic-pre-exposure-prophylaxis-prep-initiation-and-maintenance-home-care-system-127161https://curecurrent.com/trials/traditional-healer-initiated-hiv-counseling-and-testing-in-south-africa-127162https://curecurrent.com/trials/efficacy-of-serious-game-interventions-on-hcv-education-for-hiv-patients-127163https://curecurrent.com/trials/efficacy-of-switching-to-dtg-3tc-in-virologically-suppressed-adults-currently-on-b-f-taf-127164https://curecurrent.com/trials/effect-of-galantamine-on-inflammation-and-cognition-127165https://curecurrent.com/trials/dolutegravir-rilpivirine-antiretroviral-efficacy-study-using-real-world-data-in-subjects-with-human-immunodeficiency-vir-127166https://curecurrent.com/trials/clinical-trial-of-hiv-vaccine-combinations-in-healthy-men-and-women-127167https://curecurrent.com/trials/gonoscreen-efficacy-of-screening-stis-in-msm-127168https://curecurrent.com/trials/a-study-to-evaluate-the-antiviral-effect-safety-and-tolerability-of-gsk3810109a-in-viremic-human-immunodeficiency-virus-127169https://curecurrent.com/trials/an-italian-observation-of-antiretroviral-treatment-in-participants-taking-darunavir-cobicistat-plus-emtricitabine-and-te-127170https://curecurrent.com/trials/establishment-of-a-database-of-hiv-subjects-initiating-or-simplifying-dual-therapy-with-dolutegravir-lamivudine-127171https://curecurrent.com/trials/antiretroviral-regimens-containing-raltegravir-for-prophylaxis-of-mother-to-child-transmission-of-hiv-infection-127172https://curecurrent.com/trials/humoral-and-cellular-immunity-against-sars-cov-2-vaccine-in-hiv-infected-patients-immunosuppressed-127173https://curecurrent.com/trials/remember-reducing-early-mortality-morbidity-by-empiric-tuberculosis-tb-treatment-127174https://curecurrent.com/trials/couples-art-adherence-intervention-for-pwid-in-kazakhstan-127175https://curecurrent.com/trials/the-expand-study-pharmacist-administered-long-acting-cabotegravir-rilpivirine-to-expand-access-for-people-with-hiv-127176https://curecurrent.com/trials/caregiver-peer-support-and-art-adherence-among-children-127177https://curecurrent.com/trials/observational-study-on-tolerability-and-observance-of-post-exposure-prophylaxis-with-doravirine-in-hiv-viral-risk-127178https://curecurrent.com/trials/telehepc-treatment-trial-127179https://curecurrent.com/trials/assess-the-performance-of-metagenomic-sequencing-in-the-diagnosis-of-sti-ngs-ist-127180https://curecurrent.com/trials/incidence-of-metabolic-syndrome-in-people-living-with-hiv-without-experience-to-art-who-start-dolutegravir-based-regimen-127181https://curecurrent.com/trials/the-implementation-of-pre-exposure-prophylaxis-of-injectable-cabotegravir-127182https://curecurrent.com/trials/long-acting-biomedical-hiv-prevention-in-transgender-women-127183https://curecurrent.com/trials/clinical-trial-to-evaluate-the-effects-of-letermovir-prophylaxis-on-t-cell-immune-activation-in-participants-with-treate-127184https://curecurrent.com/trials/risk-factors-for-multidrug-resistant-bacteria-colonization-among-patients-at-high-risk-of-stis-127185https://curecurrent.com/trials/pharmacologic-strategies-to-use-the-levonorgestrel-implant-in-hiv-infected-women-127186https://curecurrent.com/trials/a-promotion-and-implementation-project-of-hiv-pre-exposure-prophylaxis-among-high-risk-population-127187https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-lenacapavir-gs-6207-in-combination-with-other-antiretroviral-agents-in-peop-127188https://curecurrent.com/trials/a-phase-iv-study-to-assess-the-impact-of-the-change-of-antiretroviral-treatment-from-dual-therapy-to-triple-therapy-on-i-127189https://curecurrent.com/trials/tenofovir-lamivudine-dolutegravir-combination-as-second-line-art-a-randomised-controlled-trial-127190https://curecurrent.com/trials/hpv-infection-and-vaginal-microecology-in-immunosuppressed-women-127191https://curecurrent.com/trials/good-first-b-f-taf-as-first-line-art-127192https://curecurrent.com/trials/long-term-study-of-liver-disease-in-people-with-hepatitis-b-and-or-hepatitis-c-with-or-without-hiv-infection-127193https://curecurrent.com/trials/study-of-semaglutide-for-non-alcoholic-fatty-liver-disease-nafld-a-metabolic-syndrome-with-insulin-resistance-increased-127194https://curecurrent.com/trials/improving-maternal-health-by-reducing-malaria-in-african-hiv-women-127195https://curecurrent.com/trials/feasibility-of-the-mindfulness-based-stress-reduction-intervention-for-black-women-living-with-hiv-supplement-127196https://curecurrent.com/trials/safety-and-efficacy-of-doravirine-mk-1439-in-participants-with-human-immunodeficiency-virus-1-hiv-1-mk-1439-018-127197https://curecurrent.com/trials/improving-hiv-1-control-in-africa-with-long-acting-antiretrovirals-127198https://curecurrent.com/trials/increasing-engagement-and-improving-hiv-outcomes-via-healthmpowerment-127199https://curecurrent.com/trials/type-1-hybrid-trial-of-our-plan-a-brief-couples-based-hiv-sti-prevention-intervention-127200https://curecurrent.com/trials/phenotyping-seroconversion-following-vaccination-against-covid-19-in-patients-on-haemodialysis-study-127201https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-at-home-127202https://curecurrent.com/trials/effectiveness-of-gut-microbiota-targeted-diatery-intervention-among-older-people-living-with-hiv-127203https://curecurrent.com/trials/drug-drug-interaction-study-in-trans-women-living-with-hiv-127204https://curecurrent.com/trials/genotype-informed-versus-empiric-management-of-viremia-127205https://curecurrent.com/trials/next-generation-ingestible-sensors-for-medication-adherence-measurement-127206https://curecurrent.com/trials/case-managers-for-cvd-risk-reduction-in-hiv-clinic-127207https://curecurrent.com/trials/faisability-and-efficacity-of-the-reinforced-communautary-support-program-parc-on-the-complications-of-chemsex-127208https://curecurrent.com/trials/resilience-based-stigma-reduction-program-rise-up-127209https://curecurrent.com/trials/hiv-exposure-in-utero-and-metabolic-disease-risk-in-hiv-negative-young-adults-127210https://curecurrent.com/trials/a-gender-enhanced-pre-exposure-prophylaxis-prep-information-motivational-workshop-for-young-south-african-women-127211https://curecurrent.com/trials/testing-two-models-of-prep-delivery-in-obgyn-clinics-127212https://curecurrent.com/trials/european-pregnancy-and-paediatric-infections-cohort-collaboration-eppicc-sars-cov-2-antibody-study-protocol-covid-19-127213https://curecurrent.com/trials/study-for-ife4prep-intervention-on-prep-uptake-by-southern-african-american-women-127214https://curecurrent.com/trials/pharmacokinetics-safety-tolerability-of-dolutegravir-rilpivirine-in-pediatrics-127215https://curecurrent.com/trials/computerized-cognitive-rehabilitation-of-patients-with-cognitive-deficits-due-to-the-human-immunodeficiency-virus-127216https://curecurrent.com/trials/life-experience-of-people-aged-60-and-over-living-with-hiv-127217https://curecurrent.com/trials/hiv-care-cascade-and-linkage-to-antiretroviral-therapy-among-hospitalized-adults-in-lusaka-zambia-127218https://curecurrent.com/trials/anti-cd-19-car-t-cell-therapy-in-patients-with-anca-vasculitis-127219https://curecurrent.com/trials/istep-an-mhealth-physical-activity-and-diet-intervention-for-persons-with-hiv-127220https://curecurrent.com/trials/pharmacokinetics-of-plasma-doravirine-once-daily-over-72-hours-following-drug-intake-cessation-in-healthy-volunteers-127221https://curecurrent.com/trials/nutrition-education-intervention-for-plhiv-127222https://curecurrent.com/trials/biomarkers-for-event-driven-prep-adherence-127223https://curecurrent.com/trials/change-in-body-weight-and-bmi-in-pwh-with-dor-3tc-tdf-compared-with-insti-127224https://curecurrent.com/trials/effectivity-of-protein-purified-derivative-treatment-for-anogenital-warts-in-hiv-patient-127225https://curecurrent.com/trials/immunogenicity-of-influenza-vaccines-in-hiv-infected-persons-in-thailand-127226https://curecurrent.com/trials/preventing-hiv-among-native-americans-through-the-treatment-ptsd-substance-use-127227https://curecurrent.com/trials/measuring-the-hiv-1-reservoir-during-cure-interventions-studies-merci-127228https://curecurrent.com/trials/translating-the-abcs-into-hiv-care-127229https://curecurrent.com/trials/tailored-response-to-psychiatric-comorbidity-to-improve-hiv-care-engagement-in-the-united-states-127230https://curecurrent.com/trials/efficacy-safety-tolerability-of-switching-efv-tdf-ftc-to-bic-ftc-taf-in-virologically-suppressed-adults-with-hiv-1-127231https://curecurrent.com/trials/analysis-of-the-reservoir-in-individuals-controlling-hiv-infection-127232https://curecurrent.com/trials/love-infection-a-dramatized-story-intervention-telenovela-soap-opera-for-hiv-prevention-127233https://curecurrent.com/trials/integrase-regimen-switch-to-symtuza-to-increase-tolerability-adherence-symita-127234https://curecurrent.com/trials/loviret-low-viral-reservoir-treated-patients-127235https://curecurrent.com/trials/black-men-s-care-and-intervention-to-re-engage-hiv-black-men-in-care-127236https://curecurrent.com/trials/combinado-evaluation-of-an-intervention-aimed-at-improving-hiv-outcomes-among-adolescents-and-young-adults-living-with-h-127237https://curecurrent.com/trials/evaluation-of-post-sars-cov-2-vaccinal-response-in-immunocompromised-patients-127238https://curecurrent.com/trials/abx464-in-fully-controlled-hiv-infected-patients-treated-with-boosted-protease-inhibitor-treatment-127239https://curecurrent.com/trials/drug-drug-interactions-between-rifapentine-and-dolutegravir-in-hiv-ltbi-co-infected-individuals-127240https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-pharmacokinetics-of-a-single-dose-of-vh3810109-also-known-as-gsk3810109-administer-127241https://curecurrent.com/trials/pharmacologic-strategies-for-the-etonogestrel-implant-in-hiv-infected-women-127242https://curecurrent.com/trials/suubi4her-combination-intervention-for-adolescent-girls-transitioning-into-adulthood-in-uganda-127243https://curecurrent.com/trials/young-men-s-health-project-targeting-hiv-risk-reduction-and-substance-abuse-127244https://curecurrent.com/trials/30-to-90-day-challenge-effects-of-alcohol-cessation-on-health-outcomes-127245https://curecurrent.com/trials/prevalence-of-histoplasmosis-in-hiv-patients-with-a-rapid-diagnostic-test-in-west-indies-127246https://curecurrent.com/trials/regimen-switch-to-dolutegravir-rilpivirine-from-current-antiretroviral-regimen-in-human-immunodeficiency-virus-type-1-in-127247https://curecurrent.com/trials/optimizing-a-bio-behavioral-intervention-for-sustained-viral-suppression-127248https://curecurrent.com/trials/implementing-cabenuva-in-arkansas-hiv-programs-127249https://curecurrent.com/trials/regimen-switch-to-dolutegravir-rilpivirine-from-current-antiretroviral-regimen-in-human-immunodeficiency-virus-type-1-in-127250https://curecurrent.com/trials/pk-of-taf-and-tdf-for-prep-in-pregnant-and-postpartum-women-127251https://curecurrent.com/trials/spanish-cohort-of-patients-with-hiv-infection-older-than-50-years-for-the-study-of-fragility-and-physical-function-127252https://curecurrent.com/trials/analytical-treatment-interruption-in-a-patient-with-hiv-post-allogeneic-stem-cell-transplantation-from-a-ccr5-delta32-ho-127253https://curecurrent.com/trials/program-refinements-to-optimize-model-impact-and-scalability-based-on-evidence-127254https://curecurrent.com/trials/evaluation-of-switch-to-dolutegravir-lamivudine-dtg-3tc-from-current-suppressive-antiretroviral-therapy-in-people-living-127255https://curecurrent.com/trials/evaluation-of-intermittent-triple-therapies-in-real-life-127256https://curecurrent.com/trials/raltegravir-lamivudine-abacavir-in-hiv-tuberculosis-co-infected-patients-127257https://curecurrent.com/trials/drug-drug-interaction-ddi-study-of-gsk3640254-with-darunavir-ritonavir-drv-rtv-and-etravirine-etr-127258https://curecurrent.com/trials/self-collected-vaginal-and-urine-samples-in-hiv-positive-women-127259https://curecurrent.com/trials/game-plan-for-prep-127260https://curecurrent.com/trials/immune-activation-markers-in-hiv-infected-patients-switching-to-long-acting-dual-therapy-127261https://curecurrent.com/trials/quantification-of-tenofovir-alafenamide-adherence-quanti-taf-127262https://curecurrent.com/trials/removal-of-doravirine-by-hemodialysis-in-hiv-infected-patients-with-end-stage-renal-disease-esrd-127263https://curecurrent.com/trials/effects-of-using-e-cigarettes-on-lungs-in-people-with-hiv-hbs-ancillary-127264https://curecurrent.com/trials/youth-ending-the-hiv-epidemic-127265https://curecurrent.com/trials/5-fluorouracil-following-cervical-intraepithelial-neoplasia-treatment-among-hiv-positive-women-in-east-africa-127266https://curecurrent.com/trials/outcomes-of-the-plhiv-with-suboptimal-viral-suppression-to-injectable-long-acting-antiretrovirals-127267https://curecurrent.com/trials/b-r-a-i-n-in-people-living-with-hiv-study-127268https://curecurrent.com/trials/understanding-and-reducing-hiv-risk-behavior-and-substance-use-among-self-identified-bisexual-adolescent-men-127269https://curecurrent.com/trials/a-methadone-maintenance-treatment-outcome-study-in-three-provinces-in-china-127270https://curecurrent.com/trials/behavioral-interventions-to-reduce-heavy-drinking-among-msm-in-hiv-primary-care-127271https://curecurrent.com/trials/neonatal-hiv-early-infant-diagnosis-eid-versus-standard-of-care-eid-long-term-impact-on-infant-health-life-127272https://curecurrent.com/trials/b-infantis-supplementation-to-improve-immunity-in-infants-exposed-to-hiv-127273https://curecurrent.com/trials/chemsex-health-evaluation-with-extended-release-system-for-hiv-treatment-127274https://curecurrent.com/trials/healthcare-support-for-remote-hiv-patients-127275https://curecurrent.com/trials/optimizing-the-efficiency-and-implementation-of-cash-transfers-to-improve-adherence-to-antiretroviral-therapy-phase-ii-127276https://curecurrent.com/trials/analysis-of-data-collected-from-individuals-administered-neurobehavioral-assessments-127277https://curecurrent.com/trials/epidemiological-study-of-the-markers-of-aging-in-the-cohort-of-patient-hiv-in-brest-127278https://curecurrent.com/trials/streamlining-the-efficiency-of-prep-implementation-127279https://curecurrent.com/trials/phase-2-trial-of-lactin-v-in-women-at-high-risk-of-hiv-acquisition-127280https://curecurrent.com/trials/friendship-bench-adaptation-to-improve-mental-health-hiv-care-engagement-outcomes-among-plwh-and-pwid-in-vietnam-127281https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-provision-for-ugandan-fisherfolk-127282https://curecurrent.com/trials/impact-of-weekly-administration-of-rifapentine-and-isoniazid-on-steady-state-pharmacokinetics-of-tenofovir-alafenamide-i-127283https://curecurrent.com/trials/drug-interactions-between-dolutegravir-and-escalating-doses-of-rifampicin-127284https://curecurrent.com/trials/prep-seguro-antiretroviral-based-hiv-prevention-among-men-at-high-risk-in-mexico-127285https://curecurrent.com/trials/randomized-control-trial-on-trauma-focused-cbt-in-zambia-127286https://curecurrent.com/trials/inpatient-package-to-reduce-hiv-and-aids-related-death-in-zambia-127287https://curecurrent.com/trials/technological-intervention-for-reducing-alcohol-use-among-people-living-with-hiv-aids-127288https://curecurrent.com/trials/pharmacokinetics-of-intracellular-tfv-dp-and-ftc-tp-in-hiv-infected-adolescents-127289https://curecurrent.com/trials/medical-practices-and-representations-of-people-from-haiti-in-french-guiana-127290https://curecurrent.com/trials/immune-activation-as-a-cause-of-insulin-resistance-in-adults-living-with-hiv-1-on-effective-antiretroviral-therapy-127291https://curecurrent.com/trials/aids-347-il-6-blockade-in-treated-hiv-infection-127292https://curecurrent.com/trials/open-trial-to-improve-retention-in-care-for-persons-with-hiv-who-use-substances-127293https://curecurrent.com/trials/the-cheeky-study-a-novel-delivery-system-for-cab-rpv-la-127294https://curecurrent.com/trials/tenofovir-emtricitabine-with-doxycycline-for-combination-hiv-and-syphilis-pre-exposure-prophylaxis-in-hiv-negative-msm-127295https://curecurrent.com/trials/a-study-to-investigate-the-relative-bioavailability-and-food-effect-of-an-oral-capsid-inhibitor-tablet-formulation-compa-127296https://curecurrent.com/trials/development-of-a-telehealth-delivered-peer-navigation-and-coping-skills-intervention-to-increase-prep-use-in-young-black-127297https://curecurrent.com/trials/characteristics-and-outcomes-of-tb-and-hiv-co-infections-127298https://curecurrent.com/trials/comorbidity-and-aging-with-hiv-127299https://curecurrent.com/trials/a-study-of-heterologous-vaccine-regimen-of-adenovirus-serotype-26-mosaic4-human-immunodeficiency-virus-ad26-mos4-hiv-adj-127300https://curecurrent.com/trials/standardized-patients-to-measure-and-address-intersectional-stigma-127301https://curecurrent.com/trials/immunity-to-yellow-fever-in-hiv-infected-patients-10-years-after-a-primary-anti-yellow-fever-vaccination-127302https://curecurrent.com/trials/neuropsychological-development-and-executive-functioning-of-children-born-to-hiv-infected-mothers-neuropsy-heu-127303https://curecurrent.com/trials/a-phase-i-study-of-safety-immunogenicity-of-aeras-456-in-hiv-neg-adults-treated-for-drug-susceptible-pulmonary-tb-127304https://curecurrent.com/trials/near-patient-study-of-the-oraquick-advance-hiv-1-2-rapid-antibody-test-in-oral-fluid-and-fingerstick-whole-blood-127305https://curecurrent.com/trials/precariousness-and-sexual-vulnerability-of-people-from-haiti-living-with-or-without-hiv-in-french-guiana-127306https://curecurrent.com/trials/effects-of-mhealth-message-on-metabolic-syndrome-and-bone-loss-of-hiv-infected-persons-in-taiwan-127307https://curecurrent.com/trials/project-engage-oral-prep-acceptability-127308https://curecurrent.com/trials/treatment-in-preventing-anal-cancer-in-patients-with-hiv-and-anal-high-grade-lesions-127309https://curecurrent.com/trials/nursing-counseling-to-the-change-of-behavior-of-alcohol-consumption-in-patients-in-haart-127310https://curecurrent.com/trials/integrated-ba-and-hiv-rr-counseling-for-msm-with-stimulant-abuse-127311https://curecurrent.com/trials/adaptive-intervention-to-facilitate-prep-uptake-adherence-among-transgender-women-127312https://curecurrent.com/trials/positive-steps-to-enhance-problem-solving-skills-127313https://curecurrent.com/trials/storytelling-to-increase-family-support-for-pre-exposure-prophylaxis-use-127314https://curecurrent.com/trials/a-real-life-study-of-the-use-of-cabotegravir-plus-rilpivirine-long-acting-in-art-experienced-pre-treated-people-with-hiv-127315https://curecurrent.com/trials/improving-the-health-of-south-african-women-with-traumatic-stress-in-hiv-care-c0147-127316https://curecurrent.com/trials/efficacy-and-safety-of-first-line-art-with-bic-ftc-taf-introduced-at-the-first-clinical-visit-127317https://curecurrent.com/trials/identification-and-treatment-of-cervical-abnormalities-in-per-through-integration-of-pocket-colposcopy-and-telemedicine-127318https://curecurrent.com/trials/the-positively-quit-trial-for-smoking-cessation-127319https://curecurrent.com/trials/alcohol-misuse-gut-microbial-dysbiosis-and-prep-care-continuum-application-and-efficacy-of-sbirt-intervention-127320https://curecurrent.com/trials/safety-and-immunogenicity-of-a-tetravalent-dengue-vaccine-in-hiv-positive-adults-127321https://curecurrent.com/trials/our-healthbox-evaluating-interactive-dispensing-systems-for-low-barrier-access-to-hiv-testing-and-harm-reduction-127322https://curecurrent.com/trials/introduction-of-dispersible-3hp-formulations-for-tb-preventive-treatment-in-children-a-multi-country-evaluation-127323https://curecurrent.com/trials/standard-versus-double-dose-dolutegravir-in-patients-with-hiv-associated-tuberculosis-127324https://curecurrent.com/trials/factors-predicting-persistence-of-oncogenic-hpv-and-cervical-dysplasia-in-hiv-infected-kenyan-women-127325https://curecurrent.com/trials/phase-2a-trial-to-evaluate-safety-and-immunogenicity-of-covid-19-vaccine-strategies-in-hiv-infected-uninfected-adults-127326https://curecurrent.com/trials/effects-of-the-anti-hiv-pill-truvada-on-gene-transcription-in-the-gastrointestinal-tract-of-hiv-uninfected-individuals-127327https://curecurrent.com/trials/a-clinical-trial-in-healthy-hiv-1-uninfected-adult-participants-to-compare-the-safety-tolerability-and-immunogenicity-of-127328https://curecurrent.com/trials/evaluation-of-doxycycline-post-exposure-prophylaxis-to-reduce-sexually-transmitted-infections-in-prep-users-and-hiv-infe-127329https://curecurrent.com/trials/effectiveness-of-gut-microbiota-targeted-diatery-intervention-among-people-living-with-hiv-127330https://curecurrent.com/trials/dose-escalation-study-to-determine-the-pharmacokinetics-of-atazanavir-administered-with-rifampicin-to-hiv-positive-adult-127331https://curecurrent.com/trials/adherence-through-home-education-and-nursing-assessment-indonesia-127332https://curecurrent.com/trials/glecaprevir-pibrentasvir-fixed-dose-combination-treatment-for-acute-hepatitis-c-virus-infection-127333https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-recombinant-hiv-1-envelope-protein-sosip-v8-2-763-vaccine-ad-127334https://curecurrent.com/trials/clinical-trial-for-evaluating-the-efficacy-and-safety-of-electrocoagulation-vs-topic-sinecatechins-vs-topic-cidofovir-wi-127335https://curecurrent.com/trials/immunogenicity-and-safety-of-a-9-valent-human-papillomavirus-vaccine-in-hiv-positive-women-127336https://curecurrent.com/trials/doxycycline-pep-for-prevention-of-sexually-transmitted-infections-among-kenyan-women-using-hiv-prep-127337https://curecurrent.com/trials/implementing-long-acting-novel-antiretrovirals-127338https://curecurrent.com/trials/evaluating-the-safety-tolerability-and-pharmacokinetics-of-monoclonal-antibodies-in-healthy-participants-127339https://curecurrent.com/trials/relative-bioavailability-trial-of-dapivirine-ring-004-and-ring-008-127340https://curecurrent.com/trials/unlimited-transportation-passes-for-unstable-housed-people-living-with-hiv-trial-127341https://curecurrent.com/trials/teleneuropsychological-intervention-in-asymptomatic-hiv-seropositive-patients-n-c-neurochange-127342https://curecurrent.com/trials/selective-estrogen-receptor-modulators-to-enhance-the-efficacy-of-viral-reactivation-with-histone-deacetylase-inhibitors-127343https://curecurrent.com/trials/improving-care-and-community-representation-for-adolescents-and-young-adults-living-with-hiv-in-west-africa-127344https://curecurrent.com/trials/nt-i7-for-kaposi-sarcoma-in-patients-with-or-without-hiv-127345https://curecurrent.com/trials/a-dose-range-finding-clinical-trial-study-in-human-immunodeficiency-virus-hiv-1-infected-treatment-naive-adults-127346https://curecurrent.com/trials/plan-and-pledge-hiv-self-testing-in-south-africa-127347https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-safety-tolerability-and-antiviral-activity-of-rilpivirine-tmc278-in-human-immun-127348https://curecurrent.com/trials/aurora-study-a-transformative-approach-to-support-prep-medication-persistence-127349https://curecurrent.com/trials/intra-lesional-nivolumab-therapy-for-limited-cutaneous-kaposi-sarcoma-127350https://curecurrent.com/trials/durvalumab-in-hiv-1-patients-with-solid-tumors-127351https://curecurrent.com/trials/acceptability-and-feasibility-of-injectable-cabotegravir-pre-exposure-prophylaxis-prep-versus-oral-prep-in-routine-care-127352https://curecurrent.com/trials/the-triple-elimination-model-of-mother-to-child-transmission-program-tri-mom-127353https://curecurrent.com/trials/the-risk-of-hiv-acquisition-among-traditional-healers-in-south-africa-127354https://curecurrent.com/trials/effect-of-cannabis-and-endocannabinoids-on-hiv-neuropathic-pain-127355https://curecurrent.com/trials/health-effects-of-the-standardized-research-e-cigarette-in-smokers-with-hiv-smokers-with-hiv-127356https://curecurrent.com/trials/pharmacokinetics-distribution-of-raltegravir-by-pet-mr-127357https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-pk-safety-and-efficacy-of-b-f-taf-in-human-immunodeficiency-virus-hiv-1-infected-127358https://curecurrent.com/trials/linkpositively-a-mobile-health-app-delivered-intervention-to-improve-hiv-care-outcomes-among-black-women-affected-by-men-127359https://curecurrent.com/trials/technology-based-community-health-nursing-to-improve-combination-anti-retroviral-therapy-cart-adherence-and-virologic-su-127360https://curecurrent.com/trials/a-phase-iib-study-to-evaluate-a-long-acting-intramuscular-regimen-for-maintenance-of-virologic-suppression-following-ind-127361https://curecurrent.com/trials/a-study-to-investigate-aldoxorubicin-in-hiv-infected-subjects-with-kaposi-s-sarcoma-127362https://curecurrent.com/trials/phase-2b-open-label-multicenter-rollover-study-to-assess-antiviral-activity-and-safety-of-long-acting-la-cabotegravir-ca-127363https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-immunogenicity-of-2-doses-of-100-g-bg505-sosip-664-gp140-vaccine-adjuvanted-given-to-127364https://curecurrent.com/trials/bioequivalence-study-to-compare-dolutegravir-50mg-film-coated-tablets-127365https://curecurrent.com/trials/assessment-of-sleep-disordersin-people-living-with-hiv-in-the-era-of-new-antiretroviral-therapies-in-north-of-france-127366https://curecurrent.com/trials/interventions-to-improve-the-hiv-prep-cascade-among-methamphetamine-users-127367https://curecurrent.com/trials/predictive-determinants-of-nephrotic-syndrome-remission-in-patients-with-at-risk-polymorphism-of-apol1-127368https://curecurrent.com/trials/pharmacokinetics-of-juluca-in-hemodialysis-127369https://curecurrent.com/trials/a-text-based-adherence-game-for-young-people-living-with-hiv-in-ghana-127370https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-cabotegravir-cab-long-acting-la-plus-rilpivirine-rpv-la-versus-biktarvy-bik-i-127371https://curecurrent.com/trials/bictegravir-in-the-elderly-living-with-hiv-bicep-127372https://curecurrent.com/trials/healthmindr-app-to-increase-pre-exposure-prophylaxis-prep-uptake-and-retention-among-men-who-have-sex-with-men-msm-127373https://curecurrent.com/trials/connect-n-unite-couples-based-hiv-sti-prevention-for-drug-involved-black-msm-127374https://curecurrent.com/trials/kenya-hiv-self-testing-in-prep-delivery-127375https://curecurrent.com/trials/arch-research-protocol-for-provider-alcohol-pharmacotherapy-training-and-assessment-127376https://curecurrent.com/trials/evaluate-and-optimize-an-online-care-model-for-prep-delivery-pilot-study-127377https://curecurrent.com/trials/sustainable-healthcenter-implementation-prep-pilot-study-127378https://curecurrent.com/trials/within-my-reach-wmr-adaptation-127379https://curecurrent.com/trials/prep-my-way-a-novel-prep-delivery-system-to-meet-the-needs-of-young-african-women-127380https://curecurrent.com/trials/quality-of-sexual-life-of-prep-users-127381https://curecurrent.com/trials/hdv-europe-prevalence-and-outcome-of-hdv-in-hiv-hbv-coinfection-127382https://curecurrent.com/trials/assisted-notification-of-partners-of-men-having-sex-with-men-discovering-their-seropositivity-127383https://curecurrent.com/trials/preventive-therapy-for-tuberculosis-in-hiv-infected-persons-127384https://curecurrent.com/trials/assessment-of-the-effectiveness-of-ta-versus-leep-for-cervical-cancer-risk-reduction-in-wlhiv-in-mozambique-127385https://curecurrent.com/trials/ccr5-modified-cd4-t-cells-for-hiv-infection-127386https://curecurrent.com/trials/descriptive-analysis-of-changes-in-hepatitis-b-markers-in-people-living-with-hiv-on-injectable-therapy-127387https://curecurrent.com/trials/project-mix-behavioral-intervention-to-reduce-risk-among-substance-using-msm-127388https://curecurrent.com/trials/a-pilot-peer-mentor-intervention-that-trains-black-men-who-have-sex-with-men-bmsm-to-use-and-promote-uptake-of-hiv-sti-s-127389https://curecurrent.com/trials/study-to-define-safety-and-effectiveness-of-dolutegravir-dtg-use-in-human-immunodeficiency-virus-hiv-positive-pregnant-w-127390https://curecurrent.com/trials/impact-of-probiotics-in-hiv-positive-patients-with-neurocognitive-disorders-127391https://curecurrent.com/trials/prep-intervention-for-people-who-inject-substances-and-use-methamphetamine-127392https://curecurrent.com/trials/two-way-texting-2wt-to-improve-antiretroviral-art-patient-retention-in-malawi-127393https://curecurrent.com/trials/efficacy-tolerability-and-acceptability-of-biktarvy-by-tplwh-127394https://curecurrent.com/trials/ete-interventions-in-the-dental-setting-127395https://curecurrent.com/trials/the-all-ireland-infectious-diseases-cohort-project-127396https://curecurrent.com/trials/exploring-racial-disparities-in-sleep-health-and-neurocognitive-function-127397https://curecurrent.com/trials/cognition-and-smoking-relapse-hcs-127398https://curecurrent.com/trials/project-werk-wellness-encouragement-respect-kinship-127399https://curecurrent.com/trials/impact-of-covid-19-on-provision-and-uptake-of-prevention-of-mother-to-child-transmission-of-hiv-services-in-zimbabwe-127400https://curecurrent.com/trials/hybrid-evaluation-of-a-home-based-hiv-pre-exposure-prophylaxis-program-127401https://curecurrent.com/trials/gut-microbiota-pgx-and-instis-response-127402https://curecurrent.com/trials/cbd-for-sleep-in-people-with-hiv-127403https://curecurrent.com/trials/triumeq-as-an-integrase-single-tablet-regimen-in-people-with-hiv-who-inject-drugs-127404https://curecurrent.com/trials/teleprep-for-at-risk-youth-in-colorado-127405https://curecurrent.com/trials/patient-reported-outcomes-in-real-life-of-cabotegravir-and-rilpivirine-127406https://curecurrent.com/trials/cabotegravir-plus-rilpivirine-long-acting-regimen-in-the-swiss-hiv-cohort-study-uptake-outcome-and-risk-factors-for-trea-127407https://curecurrent.com/trials/examining-community-based-effectiveness-of-a-substance-use-and-hiv-risk-reduction-intervention-for-young-men-of-color-127408https://curecurrent.com/trials/effect-of-aerobic-training-and-ginkgo-biloba-on-lipids-levels-in-hiv-positive-patients-undergoing-antiretroviral-treatme-127409https://curecurrent.com/trials/bftaf-elderly-switch-study-127410https://curecurrent.com/trials/a-cohort-for-evaluation-of-open-label-prep-use-and-prep-preferences-among-african-women-127411https://curecurrent.com/trials/safety-and-immunogenicity-of-chadv63-hivconsv-and-mva-hivconsv-candidate-hiv-1-vaccines-in-recently-hiv-1-infected-indiv-127412https://curecurrent.com/trials/a-phase-i-randomized-double-blind-placebo-controlled-safety-tolerability-and-immunogenicity-study-of-candidate-hiv-1-vac-127413https://curecurrent.com/trials/study-to-evaluate-the-safety-and-effect-of-hivconsv-vaccines-in-combination-with-histone-deacetylase-inhibitor-romidepsi-127414https://curecurrent.com/trials/ssri-effects-on-depression-and-immunity-in-hiv-aids-127415https://curecurrent.com/trials/expression-of-stress-markers-during-meth-treatment-express-127416https://curecurrent.com/trials/evaluation-of-the-trans-women-connected-mobile-app-for-changes-in-sexual-health-related-behavior-among-transgender-women-127417https://curecurrent.com/trials/safety-and-efficacy-of-neutralizing-antibodies-and-vaccination-for-induction-of-hiv-remission-127418https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-safety-and-immunogenicity-of-eod-gt8-60mer-mrna-vaccine-mrna-1644-and-core-g28v2-60mer-m-127419https://curecurrent.com/trials/digital-behavioral-therapy-for-sleep-problems-127420https://curecurrent.com/trials/maraviroc-efficacy-for-hepatitis-c-127421https://curecurrent.com/trials/self-management-of-hiv-among-adolescents-127422https://curecurrent.com/trials/telemedicine-for-prep-throughout-mississippi-127423https://curecurrent.com/trials/long-acting-treatment-in-adolescents-lata-127424https://curecurrent.com/trials/rapid-reinitiation-of-a-single-tablet-antiretroviral-therapy-using-symtuza-in-hiv-1-infected-treatment-experienced-patie-127425https://curecurrent.com/trials/agricultural-intervention-for-food-security-and-hiv-health-outcomes-in-kenya-127426https://curecurrent.com/trials/a-study-of-cl-197-capsules-in-healthy-participants-127427https://curecurrent.com/trials/clinical-effectiveness-implementation-hybrid-type-2-study-on-home-delivered-cabenuva-for-people-living-with-hiv-who-are-127428https://curecurrent.com/trials/serious-game-interventions-to-reduce-viral-hepatitis-c-among-plwh-msm-127429https://curecurrent.com/trials/quantitative-and-qualitative-research-for-mhealth-program-to-support-people-living-with-hiv-across-the-hiv-care-continuu-127430https://curecurrent.com/trials/pharmacokinetic-study-of-cabotegravir-and-rilpivirine-long-acting-intramuscular-injections-in-healthy-adult-participants-127431https://curecurrent.com/trials/immunologic-response-to-kansui-in-treated-hiv-individuals-a-dose-escalation-study-127432https://curecurrent.com/trials/the-antiretroviral-speed-access-program-switch-asap-switch-study-127433https://curecurrent.com/trials/nurse-led-community-health-worker-adherence-model-in-3hp-delivery-among-homeless-adults-at-risk-for-tb-infection-and-hiv-127434https://curecurrent.com/trials/feasibility-of-the-mindfulness-based-stress-reduction-intervention-for-black-women-living-with-hiv-127435https://curecurrent.com/trials/virtual-prep-rendering-prep-delivery-more-efficient-127436https://curecurrent.com/trials/a-randomised-placebo-controlled-trial-of-art-plus-dual-long-acting-hiv-specific-broadly-neutralising-antibodies-bnabs-127437https://curecurrent.com/trials/lower-urinary-tract-symptoms-in-males-living-with-hiv-127438https://curecurrent.com/trials/art-first-line-treatment-durability-in-russia-127439https://curecurrent.com/trials/role-of-exogenous-and-endogenous-sex-hormones-on-tenofovir-and-emtricitabine-disposition-in-female-genital-tract-127440https://curecurrent.com/trials/finding-barriers-and-designing-solutions-to-promote-women-s-cancer-screening-in-south-africa-127441https://curecurrent.com/trials/prevalence-of-sexually-transmitted-infections-stis-and-coinfections-in-the-general-population-127442https://curecurrent.com/trials/financial-incentives-randomization-with-stepped-treatment-trial-127443https://curecurrent.com/trials/characterization-of-hiv-1-reservoirs-in-hiv-1-non-b-infected-adolescents-on-art-in-cameroon-127444https://curecurrent.com/trials/the-respond-outcomes-study-127445https://curecurrent.com/trials/optimizing-viral-load-suppression-in-kenyan-children-on-antiretroviral-therapy-127446https://curecurrent.com/trials/gum-remote-testing-v4-0-127447https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-polyvalent-dna-gp120-hiv-vaccine-in-healthy-hiv-uninfected-adults-127448https://curecurrent.com/trials/a-study-evaluating-implementation-strategies-for-cabotegravir-cab-rilpivirine-rpv-long-acting-la-injectables-for-human-i-127449https://curecurrent.com/trials/youth-services-navigation-intervention-for-hiv-youth-being-released-from-or-at-risk-for-incarceration-127450https://curecurrent.com/trials/covid-19-recovery-study-symptoms-and-biomarkers-of-long-covid-19-in-people-living-with-and-without-hiv-127451https://curecurrent.com/trials/pharmacy-based-prep-for-young-women-who-sell-sex-in-zimbabwe-127452https://curecurrent.com/trials/a-mind-body-intervention-to-reduce-symptoms-among-people-aging-with-hiv-127453https://curecurrent.com/trials/tailoring-healthy-relationships-to-improve-hiv-outcomes-127454https://curecurrent.com/trials/transgender-youth-and-prep-pk-safety-uptake-adherence-demonstration-project-127455https://curecurrent.com/trials/effect-of-n-803-on-b-cell-follicles-in-antiretroviral-treated-hiv-disease-127456https://curecurrent.com/trials/transgender-youth-and-prep-pk-safety-uptake-adherence-pk-study-127457https://curecurrent.com/trials/randomized-pilot-study-of-a-mhealth-app-for-ambivalent-smokers-living-with-hiv-127458https://curecurrent.com/trials/transgender-youth-and-prep-pk-safety-uptake-adherence-intervention-development-127459https://curecurrent.com/trials/chopviolence-chophiv-127460https://curecurrent.com/trials/reducing-disparities-in-rural-hiv-prevention-127461https://curecurrent.com/trials/express-testing-and-same-day-initiation-of-prep-study-127462https://curecurrent.com/trials/pathtoscale-an-implementation-evaluation-127463https://curecurrent.com/trials/psychosocial-intervention-for-older-hiv-adults-with-hand-127464https://curecurrent.com/trials/smartphone-intervention-for-smoking-cessation-and-improving-adherence-to-treatment-among-hiv-patients-127465https://curecurrent.com/trials/safety-and-survival-of-genetically-modified-white-blood-cells-in-hiv-infected-twins-the-gemini-study-127466https://curecurrent.com/trials/adjunctive-corticosteroids-for-tuberculous-meningitis-in-hiv-infected-adults-the-act-hiv-trial-127467https://curecurrent.com/trials/immune-correlates-of-cardiac-structure-and-function-127468https://curecurrent.com/trials/evaluating-the-safety-pharmacokinetics-and-anti-viral-activity-of-vrc01-and-vrc01ls-in-the-serum-and-mucosa-of-healthy-h-127469https://curecurrent.com/trials/vaccine-therapy-in-preventing-hpv-in-hiv-positive-women-in-india-127470https://curecurrent.com/trials/pathogen-detection-in-hiv-infected-children-with-non-malarial-febrile-illnesses-using-metagenomic-sequencing-127471https://curecurrent.com/trials/study-to-evaluate-the-safety-and-immunogenicity-of-an-oral-hiv-vaccine-in-healthy-hiv-uninfected-adults-127472https://curecurrent.com/trials/an-intervention-to-improve-hiv-pre-exposure-prophylaxis-initiation-adherence-and-linkage-to-care-for-recently-incarcerat-127473https://curecurrent.com/trials/standing-tall-yima-nkqo-127474https://curecurrent.com/trials/get-connected-efficacy-trial-127475https://curecurrent.com/trials/behavioral-economics-incentives-to-support-hiv-treatment-adherence-in-sub-saharan-africa-127476https://curecurrent.com/trials/pharmacy-delivery-to-expand-the-reach-of-prep-in-kenya-127477https://curecurrent.com/trials/the-study-for-the-cervical-cancer-screening-and-treatment-algorithms-study-using-hpv-testing-in-africa-127478https://curecurrent.com/trials/dash-decision-making-in-adolescent-sexual-health-127479https://curecurrent.com/trials/internet-based-video-conferencing-to-address-alcohol-use-and-pain-a-pilot-trial-127480https://curecurrent.com/trials/the-wise-app-trial-for-improving-health-outcomes-in-plwh-127481https://curecurrent.com/trials/a-relative-bioavailability-and-food-effect-study-of-the-fixed-dose-combination-of-gsk3640254-and-dolutegravir-dtg-in-hea-127482https://curecurrent.com/trials/acceptability-and-performance-of-hiv-self-testing-in-a-youth-population-in-nigeria-127483https://curecurrent.com/trials/study-of-self-amplifying-messenger-ribonucleic-acid-samrna-vaccines-against-covid-19-in-healthy-adults-and-people-living-127484https://curecurrent.com/trials/health-and-migration-trajectories-of-housekeepers-in-bamako-127485https://curecurrent.com/trials/undetectable-untransmissible-in-thailand-888-64-127486https://curecurrent.com/trials/screening-anal-hpv-colonization-in-men-sex-men-using-pre-exposure-prophylaxis-for-hiv-anaprep-hpv-127487https://curecurrent.com/trials/an-educational-intervention-program-to-improve-the-oral-health-of-hiv-positive-children-in-kano-nigeria-127488https://curecurrent.com/trials/movida-1-ter-evaluation-of-the-cobas-plasma-separation-card-in-the-field-in-vietnam-127489https://curecurrent.com/trials/evaluation-of-hcv-care-and-treatment-for-hiv-hcv-co-infected-patients-in-decentralised-areas-in-vietnam-127490https://curecurrent.com/trials/observational-study-for-the-evaluation-of-the-role-of-hiv-1-tat-protein-and-anti-tat-immune-response-in-hiv-reservoir-127491https://curecurrent.com/trials/bictegravir-emtricitabine-tenofovir-alafenide-plus-doravirine-127492https://curecurrent.com/trials/a-multicenter-prospective-clinical-cohort-study-on-the-pathogen-spectrum-of-hiv-aids-complicated-with-infection-127493https://curecurrent.com/trials/strategic-timing-of-antiretroviral-treatment-127494https://curecurrent.com/trials/the-hiv-testing-using-enhanced-screening-techniques-in-emergency-departments-trial-127495https://curecurrent.com/trials/study-to-assess-adverse-events-and-how-intravenous-iv-or-subcutaneous-sc-abbv-382-moves-through-the-body-of-adult-partic-127496https://curecurrent.com/trials/reducing-the-residual-reservoir-of-hiv-1-infected-cells-in-patients-receiving-antiretroviral-therapy-127497https://curecurrent.com/trials/switching-from-protease-inhibitor-ritonavir-to-generic-single-tablet-regimen-of-tenofovir-alafenamide-emtricitibine-dolu-127498https://curecurrent.com/trials/effectiveness-of-gut-microbiota-targeted-dietary-intervention-among-hiv-infected-patients-127499https://curecurrent.com/trials/the-effect-of-pregnancy-on-the-pk-of-isentress-a-longitudinal-investigation-in-the-second-and-third-trimesters-127500https://curecurrent.com/trials/adherence-to-hiv-treatment-postpartum-the-implications-of-transitions-among-women-living-with-hiv-in-south-africa-127501https://curecurrent.com/trials/covid-19-and-hiv-in-health-workers-in-mozambique-127502https://curecurrent.com/trials/studying-topiramate-for-re-activating-the-hiv-1-reservoir-127503https://curecurrent.com/trials/dolutegravir-and-clinical-outcomes-among-art-recipients-in-brazil-127504https://curecurrent.com/trials/effect-of-u-u-messaging-on-hiv-in-south-africa-127505https://curecurrent.com/trials/ph1-study-of-ft538-alone-and-with-vorinostat-for-persistent-low-level-hiv-viremia-127506https://curecurrent.com/trials/pembrolizumab-in-progressive-multifocal-leukoencephalopathy-pml-in-immunocompromised-patients-without-hiv-infection-127507https://curecurrent.com/trials/intervention-of-hiv-drug-use-and-the-criminal-justice-system-in-malaysia-127508https://curecurrent.com/trials/impact-of-long-acting-injectable-cabotegravir-for-hiv-prep-in-msm-in-france-127509https://curecurrent.com/trials/eradicating-cervical-cancer-in-kenya-127510https://curecurrent.com/trials/evaluation-of-the-acceptability-and-safety-of-the-shangring-device-for-male-circumcision-in-shinyanga-tanzania-127511https://curecurrent.com/trials/efficacy-of-dolutegravir-plus-lamivudine-in-hiv-1-infected-treatment-na-ve-adults-without-a-baseline-genotyping-test-127512https://curecurrent.com/trials/antiretroviral-speed-access-program-127513https://curecurrent.com/trials/an-economic-and-relationship-strengthening-intervention-for-hiv-affected-couples-who-drink-alcohol-in-malawi-127514https://curecurrent.com/trials/inflammation-and-cardiovascular-health-in-women-127515https://curecurrent.com/trials/a-study-to-determine-safety-and-efficacy-of-dolutegravir-abacavir-lamivudine-dtg-abc-3tc-in-human-immunodeficiency-virus-127516https://curecurrent.com/trials/techstep-technology-based-stepped-care-to-stem-transgender-adolescent-risk-transmission-127517https://curecurrent.com/trials/clinical-trial-investigating-the-safety-and-immunogenicity-of-gbs6-in-pregnant-women-with-and-without-hiv-prepare-127518https://curecurrent.com/trials/developing-online-interventions-to-reduce-stigma-related-stress-sexual-health-and-hiv-risk-among-young-chinese-msm-127519https://curecurrent.com/trials/an-accessible-digital-intervention-to-promote-hiv-testing-counseling-and-prevention-among-adolescents-127520https://curecurrent.com/trials/duopact-pilot-intervention-127521https://curecurrent.com/trials/exploring-the-feasibility-of-a-peer-driven-intervention-to-improve-hiv-prevention-among-prisoners-who-inject-drugs-127522https://curecurrent.com/trials/human-immunodeficiency-virus-pre-exposure-prophylaxis-program-in-general-practice-127523https://curecurrent.com/trials/interrupting-hiv-and-tb-stigma-in-the-household-in-uganda-127524https://curecurrent.com/trials/ex-vivo-characterization-and-targeting-of-the-latent-hiv-infected-reservoir-to-cure-hiv-127525https://curecurrent.com/trials/a-prospective-cohort-for-ex-vivo-cure-studies-with-chronic-hiv-infected-patients-in-the-netherlands-127526https://curecurrent.com/trials/observational-study-of-solid-organ-transplantation-utilizing-hiv-positive-donors-in-hiv-positive-recipients-127527https://curecurrent.com/trials/national-survey-about-trajectory-and-life-conditions-of-hiv-trans-people-in-france-127528https://curecurrent.com/trials/prep2prevent-an-online-prep-navigation-and-activation-intervention-127529https://curecurrent.com/trials/combination-latency-reversal-with-high-dose-disulfiram-plus-vorinostat-in-hiv-infected-individuals-on-art-127530https://curecurrent.com/trials/monitored-antiretroviral-pause-in-chronic-hiv-infected-subjects-with-long-lasting-suppressed-viremia-127531https://curecurrent.com/trials/observational-retrospective-analysis-in-hiv-1-infected-patients-oraswiral-127532https://curecurrent.com/trials/sequential-analysis-before-and-after-treatment-initiation-to-unravel-the-role-of-naturally-occurring-extracellular-vesic-127533https://curecurrent.com/trials/duo-partnership-adherence-commitment-therapy-127534https://curecurrent.com/trials/efficacy-of-bic-f-taf-versus-standard-of-care-in-the-treatment-of-new-hiv-infection-diagnoses-in-the-context-of-test-and-127535https://curecurrent.com/trials/psychoeducation-relaxation-problem-solving-activation-cognitive-coping-therapy-for-adolescents-and-youth-in-hiv-care-127536https://curecurrent.com/trials/prevalence-and-risk-factors-of-hiv-infections-in-transgender-and-non-binary-people-in-flanders-and-brussels-belgium-127537https://curecurrent.com/trials/hiv-pre-exposure-prophylaxis-implementation-hong-kong-study-127538https://curecurrent.com/trials/optimization-of-a-tenofovir-enema-for-hiv-prevention-127539https://curecurrent.com/trials/safety-and-immunogenicity-of-pdna-vaccines-expressing-hiv-m-group-p24-gag-conserved-elements-and-or-p55-gag-administered-127540https://curecurrent.com/trials/evaluation-of-pre-exposure-prophylaxis-against-hiv-in-alpine-region-127541https://curecurrent.com/trials/a-crossover-adherence-and-acceptability-study-assessing-a-dpp-capsule-for-hiv-and-pregnancy-prevention-127542https://curecurrent.com/trials/a-crossover-acceptability-study-assessing-a-dpp-capsule-for-hiv-and-pregnancy-prevention-127543https://curecurrent.com/trials/hiv-education-kit-for-adolescents-pencegahan-hiv-di-kalangan-remaja-prem-kit-127544https://curecurrent.com/trials/optimizing-reversal-of-hiv-latency-with-combination-therapy-127545https://curecurrent.com/trials/comparison-of-two-intrauterine-devices-iuds-among-cape-town-hiv-positive-women-127546https://curecurrent.com/trials/doxycycline-pep-and-4cmenb-as-a-comprehensive-prevention-strategy-in-msm-and-tgw-at-high-risk-for-bacterial-stis-within-127547https://curecurrent.com/trials/prep-communication-intervention-for-female-clients-of-a-needle-exchange-127548https://curecurrent.com/trials/hst-for-female-sex-workers-drug-users-in-kazakhstan-127549https://curecurrent.com/trials/optimisation-of-care-in-vulnerable-hiv-infected-individuals-127550https://curecurrent.com/trials/phase-i-open-label-dose-escalation-study-of-a-human-monoclonal-antibody-vrc-hivmab091-00-ab-n6ls-administered-intravenou-127551https://curecurrent.com/trials/pharmacokinetics-of-twice-or-once-daily-dtg-50mg-in-children-with-hiv-and-tb-127552https://curecurrent.com/trials/implementation-of-rapid-hiv-self-testing-among-msm-project-127553https://curecurrent.com/trials/hiv-study-on-measuring-the-reservoir-on-cellular-level-to-cure-infection-127554https://curecurrent.com/trials/doravirine-islatravir-dor-isl-in-pediatric-participants-with-human-immunodeficiency-virus-type-1-hiv-1-who-are-18-years-127555https://curecurrent.com/trials/copana-a09-pcsk-9-substudy-impact-of-protease-inhibitors-on-pcsk9-levels-in-naive-hiv-infected-patients-127556https://curecurrent.com/trials/pilot-implementation-of-hiv-self-testing-delivery-in-private-pharmacies-combined-to-a-respondent-driven-sampling-method-127557https://curecurrent.com/trials/task-shifted-adaptation-of-the-who-pen-intervention-to-address-cardio-metabolic-complications-in-people-living-with-hiv-127558https://curecurrent.com/trials/project-adhere-clinical-proof-of-concept-of-a-tenofovir-tfv-aptamer-based-biosensor-127559https://curecurrent.com/trials/register-of-cardiovascular-complications-among-people-living-with-hiv-127560https://curecurrent.com/trials/long-term-follow-up-of-hiv-subjects-exposed-to-sb-728-t-or-sb-728mr-t-127561https://curecurrent.com/trials/immunocompromised-swiss-cohorts-based-trial-platform-127562https://curecurrent.com/trials/study-of-interferon-gamma-in-the-complex-treatment-of-patients-infected-with-hiv-and-tuberculosis-127563https://curecurrent.com/trials/papuan-indigenous-model-of-male-circumcision-127564https://curecurrent.com/trials/advanced-hiv-prevention-prep-chicago-127565https://curecurrent.com/trials/study-of-betalutin-for-treatment-of-relapsed-or-refractory-non-hodgkin-lymphoma-lymrit-37-05-127566https://curecurrent.com/trials/pharmacogenomics-of-new-antiretrovirals-127567https://curecurrent.com/trials/pharmacokinetics-and-safety-of-sar441236-127568https://curecurrent.com/trials/a-phase-1-trial-to-evaluate-cap256v2ls-in-healthy-adults-127569https://curecurrent.com/trials/integrating-ag-rdts-for-covid-19-in-mnch-hiv-and-tb-services-in-cameroon-and-kenya-127570https://curecurrent.com/trials/hiv-prevention-with-adolescents-neurocognitive-deficits-and-treatment-response-127571https://curecurrent.com/trials/open-label-study-comparing-efficacy-and-safety-of-atv-rtv-3tc-with-atv-rtv-tdf-ftc-in-hiv-infected-treatment-na-ve-subje-127572https://curecurrent.com/trials/peer-led-hiv-self-testing-among-men-in-two-ugandan-fishing-communities-127573https://curecurrent.com/trials/home-link-post-hospital-care-to-reduce-hiv-mortality-in-south-africa-127574https://curecurrent.com/trials/an-intervention-to-improve-antenatal-access-to-cd4-testing-and-haart-in-botswana-127575https://curecurrent.com/trials/impact-of-smoking-and-its-cessation-on-systemic-and-airway-immune-activation-127576https://curecurrent.com/trials/evaluation-of-pharmacokinetic-interaction-between-gsk3640254-and-caffeine-metoprolol-montelukast-flurbiprofen-omeprazole-127577https://curecurrent.com/trials/isisekelo-sempilo-trial-to-optimize-peer-thetha-nami-delivery-of-hiv-prevention-to-young-people-in-rural-kwazulu-natal-127578https://curecurrent.com/trials/mhealth-for-prep-adherence-by-young-adult-msm-phase-2-127579https://curecurrent.com/trials/single-cell-cbd-biomarkers-of-inflammation-reduction-in-people-living-with-hiv-127580https://curecurrent.com/trials/longer-acting-prep-in-transgender-and-gender-diverse-texans-127581https://curecurrent.com/trials/prevalence-of-advanced-fibrosis-in-patients-living-with-hiv-127582https://curecurrent.com/trials/pilot-test-of-a-couple-based-medication-adherence-intervention-for-hiv-positive-women-and-their-male-partners-in-south-a-127583https://curecurrent.com/trials/safety-and-pharmacokinetic-study-of-tenofovir-alafenamide-taf-elvitegravir-evg-administered-rectally-127584https://curecurrent.com/trials/adolescent-to-adult-patient-centered-hiv-transition-adapt-study-127585https://curecurrent.com/trials/amphotericin-b-for-non-hiv-cryptococcal-meningitis-patients-127586https://curecurrent.com/trials/kentucky-communities-and-researchers-engaging-to-halt-the-opioid-epidemic-care2hope-127587https://curecurrent.com/trials/innovative-tools-to-expand-hiv-self-testing-127588https://curecurrent.com/trials/study-of-bictegravir-emtricitavine-tenofovir-alafenamide-in-hiv-1-infected-na-ve-patients-using-test-and-treat-stategy-r-127589https://curecurrent.com/trials/lamp-assay-for-the-diagnosis-of-visceral-leishmaniasis-127590https://curecurrent.com/trials/effect-of-formal-letter-of-invitation-on-male-partner-involvement-at-antenatal-care-clinic-127591https://curecurrent.com/trials/second-line-treatment-of-hiv-1-with-ritonavir-boosted-atazanavir-or-darunavir-with-an-optimized-nrti-backbone-127592https://curecurrent.com/trials/asap-access-to-syringes-at-pharmacies-for-the-prevention-of-bloodborne-infections-among-people-who-inject-drugs-127593https://curecurrent.com/trials/pharmacokinetics-and-safety-of-dolutegravir-in-neonate-127594https://curecurrent.com/trials/clinic-based-art-diagnostic-evaluation-127595https://curecurrent.com/trials/a-cohort-study-on-the-clinical-characteristics-and-prognosis-of-hiv-aids-patients-infected-with-sars-cov-2-127596https://curecurrent.com/trials/a-clinical-trial-of-gsk3640254-dolutegravir-dtg-in-human-immunodeficiency-virus-1-infected-treatment-naive-adults-127597https://curecurrent.com/trials/a-randomized-double-blinded-placebo-controlled-dose-escalation-phase-1-clinical-trial-to-evaluate-the-safety-and-immunog-127598https://curecurrent.com/trials/impact-of-a-dolutegravir-based-regimen-on-early-mortality-of-aids-patients-127599https://curecurrent.com/trials/a-study-to-assess-the-food-effect-and-the-relative-bioavailability-of-the-cabotegravir-cab-pediatric-dispersible-tablet-127600https://curecurrent.com/trials/the-influence-of-concurrent-oral-calcium-carbonate-supplementation-on-steady-state-pharmacokinetics-of-oral-raltegravir-127601https://curecurrent.com/trials/efv-pharmacokinetics-pharmacogenomics-in-older-hiv-infected-patients-127602https://curecurrent.com/trials/access-to-infertility-services-clinic-perspective-127603https://curecurrent.com/trials/effectiveness-of-coping-training-for-people-with-hiv-experiencing-treatment-side-effects-the-balance-project-127604https://curecurrent.com/trials/a-study-to-evaluate-virologic-response-in-participants-newly-diagnosed-with-hiv-1-127605https://curecurrent.com/trials/postpartum-pre-exposure-prophylaxis-prep-study-to-evaluate-an-adherence-promotion-package-for-postpartum-women-on-prep-127606https://curecurrent.com/trials/evaluation-of-secondary-distribution-of-hiv-self-screening-tests-by-women-with-hiv-127607https://curecurrent.com/trials/2000-hiv-human-functional-genomics-partnership-program-127608https://curecurrent.com/trials/efficacy-of-zoledronic-acid-colaren-vs-zoledronic-acid-conventional-treatment-for-osteoporosis-in-hiv-and-hiv-men-127609https://curecurrent.com/trials/a-brief-affirmation-intervention-on-hiv-related-distress-and-positive-living-in-lesotho-127610https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-comparing-dolutegravir-dtg-plus-lamivudine-3tc-with-dolutegravir-plus-tenofovi-127611https://curecurrent.com/trials/effect-of-therapeutic-and-supratherapeutic-oral-doses-of-gsk3640254-on-cardiac-conduction-compared-to-placebo-and-a-sing-127612https://curecurrent.com/trials/oregon-prep-at-home-study-127613https://curecurrent.com/trials/relative-bioavailability-study-to-investigate-a-potential-interaction-between-dtg-dt-and-f-taf-tos-127614https://curecurrent.com/trials/mobile-phone-text-messaging-plus-motivational-interviewing-effects-on-breastfeeding-child-health-outcomes-127615https://curecurrent.com/trials/a-16-week-study-of-pirenzepine-or-placebo-to-treat-hiv-associated-distal-sensory-polyneuropathy-in-patients-with-hiv-127616https://curecurrent.com/trials/dual-boosted-protease-inhibitor-pi-pharmacokinetics-pk-trial-tipranavir-ritonavir-in-highly-treatment-experienced-hiv-1-127617https://curecurrent.com/trials/a-pharmacokinetic-study-to-assess-nevirapine-viramune-levels-in-hiv-infected-patients-with-impaired-hepatic-functions-127618https://curecurrent.com/trials/evaluation-of-pre-exposure-prophylaxis-cascade-in-pregnant-and-breastfeeding-women-in-cape-town-formative-study-127619https://curecurrent.com/trials/3-tpv-rtv-doses-in-multiple-arv-experienced-patients-tipranavir-dose-defining-study-127620https://curecurrent.com/trials/prospective-cohort-of-hiv-hbv-coinfected-patients-in-europe-127621https://curecurrent.com/trials/hiv-testing-at-family-planning-clinics-in-mombasa-county-kenya-127622https://curecurrent.com/trials/rapid-start-vs-standard-start-antiretroviral-therapy-art-in-hiv-127623https://curecurrent.com/trials/collaborative-care-for-the-detection-and-management-of-depression-among-adults-receiving-antiretroviral-therapy-in-south-127624https://curecurrent.com/trials/an-observational-study-of-distress-immune-function-and-pain-in-hiv-127625https://curecurrent.com/trials/dual-therapy-with-boosted-darunavir-dolutegravir-127626https://curecurrent.com/trials/effectiveness-of-the-q-hpv-vaccine-9-years-post-vaccination-among-hiv-positive-adolescents-127627https://curecurrent.com/trials/the-burden-of-neuro-cysticercosis-among-people-living-with-hiv-in-rural-tanzania-127628https://curecurrent.com/trials/poor-sleep-and-inflammation-in-hiv-infected-adults-127629https://curecurrent.com/trials/preparing-for-pharmacy-based-delivery-of-long-acting-injectable-antiretroviral-therapy-lai-art-127630https://curecurrent.com/trials/adapting-and-evaluating-a-tobacco-use-cessation-program-for-people-living-with-hiv-in-uganda-and-zambia-127631https://curecurrent.com/trials/healing-our-hearts-minds-and-bodies-cvd-reduction-in-persons-with-hiv-127632https://curecurrent.com/trials/identification-of-broadly-hiv-1-neutralizing-antibodies-bnab-in-hiv-infected-patients-in-mbeya-tanzania-127633https://curecurrent.com/trials/sars-cov-2-covid-19-antibody-prevalence-in-an-adult-london-hiv-cohort-127634https://curecurrent.com/trials/2000hiv-trained-innate-immunity-in-hiv-elite-controllers-127635https://curecurrent.com/trials/a-novel-regimen-to-prevent-malaria-and-sti-in-pregnant-women-with-hiv-127636https://curecurrent.com/trials/metagenomic-next-generation-sequencing-guides-anti-infection-strategies-127637https://curecurrent.com/trials/radiopaque-matrix-mk-8591-implant-in-participants-at-low-risk-for-human-immunodeficiency-virus-type-1-hiv-1-infection-mk-127638https://curecurrent.com/trials/vital-start-brief-facility-based-video-intervention-127639https://curecurrent.com/trials/clinical-application-of-cytokine-adsorption-technique-in-aids-patients-with-severe-pneumonia-and-or-septic-shock-127640https://curecurrent.com/trials/relationships-among-inflammation-physical-and-mental-health-in-subjects-with-chronic-inflammatory-physical-diseases-127641https://curecurrent.com/trials/maternal-pertussis-wholecell-responses-127642https://curecurrent.com/trials/provide-miner-friendly-services-for-integrated-tb-hiv-care-in-lesotho-study-127643https://curecurrent.com/trials/sexual-confidence-cbt-for-social-anxiety-disorder-with-hiv-risk-reduction-counselling-for-hiv-negative-gbmsm-127644https://curecurrent.com/trials/bone-inflammation-gut-and-renal-biomarkers-in-antiretroviral-na-ve-hiv-1-positive-subjects-127645https://curecurrent.com/trials/exercise-training-to-improve-brain-health-in-older-hiv-individuals-127646https://curecurrent.com/trials/vorinostat-and-combination-chemotherapy-with-rituximab-in-treating-patients-with-hiv-related-diffuse-large-b-cell-non-ho-127647https://curecurrent.com/trials/enhanced-linkage-to-hiv-care-following-home-based-hiv-testing-in-rural-uganda-127648https://curecurrent.com/trials/risk-identification-factors-for-pulmonary-function-impairment-in-aids-patients-recovered-from-severe-pneumonia-127649https://curecurrent.com/trials/acceptance-and-commitment-therapy-for-aging-people-living-with-hiv-in-chronic-pain-127650https://curecurrent.com/trials/peer-led-outreach-to-engage-male-partners-of-pregnant-women-in-uganda-okutuuka-study-127651https://curecurrent.com/trials/implementing-oral-event-driven-and-daily-and-long-acting-pre-exposure-prophylaxis-in-mobile-men-in-sub-saharan-africa-127652https://curecurrent.com/trials/safety-study-of-monoclonal-antibodies-to-reduce-the-vaginal-transmission-of-hsv-and-hiv-127653https://curecurrent.com/trials/gut-microbiome-in-people-living-with-hiv-and-hbv-127654https://curecurrent.com/trials/trends-in-risk-factors-for-mother-to-child-transmission-of-hepatitis-c-among-a-southern-european-population-127655https://curecurrent.com/trials/hiv-infection-and-risk-related-coinfections-comorbidities-in-indonesia-127656https://curecurrent.com/trials/consequences-of-marijuana-use-in-hiv-infected-youth-127657https://curecurrent.com/trials/tambua-mapema-plus-to-discover-hiv-infection-early-and-prevent-onward-transmission-127658https://curecurrent.com/trials/transgender-men-s-perspectives-on-hiv-risk-and-hiv-prevention-interventions-127659https://curecurrent.com/trials/memo-medical-marijuana-and-opioids-study-127660https://curecurrent.com/trials/safety-and-efficacy-clinical-study-of-kl-hiv-tri01-in-the-treatment-of-hiv-infected-subjects-127661https://curecurrent.com/trials/pilot-study-of-the-effects-of-exercise-on-aging-among-older-persons-with-hiv-127662https://curecurrent.com/trials/impact-of-schemas-cognitive-emotion-regulation-on-quality-of-life-of-hiv-patients-assessing-outcomes-of-cbt-127663https://curecurrent.com/trials/adherence-suppression-resistance-relationships-for-atripla-compared-to-historical-antiretroviral-regimens-127664https://curecurrent.com/trials/a-digital-intervention-for-hiv-prevention-in-black-adolescent-girls-127665https://curecurrent.com/trials/anal-hpv-tests-in-screening-for-cell-changes-in-the-anus-in-patients-with-hiv-127666https://curecurrent.com/trials/fanmi-community-cohort-care-for-hiv-infected-adolescent-girls-in-haiti-127667https://curecurrent.com/trials/b-f-taf-switch-study-for-hiv-hbv-coinfection-127668https://curecurrent.com/trials/stimulant-use-and-methylation-in-hiv-127669https://curecurrent.com/trials/mopati-a-pilot-hiv-treatment-partner-intervention-in-botswana-127670https://curecurrent.com/trials/duration-of-dual-antiretroviral-therapy-in-virologically-suppressed-people-living-with-hiv-and-factors-associated-with-s-127671https://curecurrent.com/trials/data-analysis-for-04-c-0234-tenofovir-disoproxil-fumarate-salvage-therapy-in-hiv-infected-children-and-a-study-of-its-ef-127672https://curecurrent.com/trials/alternative-tenofovir-dosing-in-adults-with-moderate-renal-function-impairment-127673https://curecurrent.com/trials/cognitive-behavioral-therapy-on-adherence-and-depression-cbt-ad-among-hiv-aids-patients-127674https://curecurrent.com/trials/user-friendly-hiv-testing-and-counseling-services-127675https://curecurrent.com/trials/tenofovir-rectal-douche-to-prevent-hiv-transmission-among-adolescents-atn-dream-127676https://curecurrent.com/trials/pluscare-mobile-platform-to-increase-linkage-to-care-in-adolescents-living-with-hiv-aids-127677https://curecurrent.com/trials/efficacy-of-doravirine-dolutegravir-dual-therapy-in-the-context-of-antiretroviral-therapy-switch-127678https://curecurrent.com/trials/reducing-time-to-spaced-out-appointments-for-newly-diagnosed-people-living-with-hiv-127679https://curecurrent.com/trials/research-in-viral-eradication-of-hiv-reservoirs-127680https://curecurrent.com/trials/peer-led-social-media-intervention-to-prevent-hiv-among-young-men-who-have-sex-with-men-ymsm-127681https://curecurrent.com/trials/manicaland-vmmc-uptake-through-behavioural-incentives-trial-127682https://curecurrent.com/trials/safer-conception-for-women-understanding-use-of-periconception-prep-127683https://curecurrent.com/trials/intsha-interactive-transition-support-for-hiv-infected-adolescents-using-social-media-127684https://curecurrent.com/trials/regimen-switch-to-dolutegravir-lamivudine-fixed-dose-combination-from-current-antiretroviral-regimen-in-hiv-1-infected-a-127685https://curecurrent.com/trials/learn-to-quit-hiv-pilot-study-127686https://curecurrent.com/trials/raltegravir-based-antiretroviral-versus-maintaining-any-other-antiretroviral-therapy-in-hiv-mono-infected-patients-127687https://curecurrent.com/trials/alcohol-drinkers-exposure-to-preventive-therapy-for-tb-adeptt-127688https://curecurrent.com/trials/improving-hiv-outcomes-among-african-american-transgender-women-127689https://curecurrent.com/trials/inducing-immune-quiescence-the-genital-tract-with-asa-127690https://curecurrent.com/trials/same-day-prep-initiation-and-sexual-health-for-transgender-women-127691https://curecurrent.com/trials/transgender-men-and-hiv-in-uganda-prep-uptake-and-persistence-127692https://curecurrent.com/trials/switch-to-dovato-in-patients-suppressed-on-biktarvy-sound-127693https://curecurrent.com/trials/prospective-hiv-chemotherapy-cohort-study-127694https://curecurrent.com/trials/study-of-an-investigational-regimen-including-fda-approved-hiv-drugs-in-hiv-infected-pediatric-subjects-127695https://curecurrent.com/trials/chemotherapy-stereotactic-body-radiation-therapy-nelfinavir-mesylate-in-locally-advanced-pancreatic-cancer-127696https://curecurrent.com/trials/stereotactic-radiation-nelfinavir-mesylate-neoadjuvant-chemotherapy-in-locally-advanced-pancreatic-cancer-127697https://curecurrent.com/trials/soy-modulation-of-immune-activation-ldl-levels-and-lowering-inflammation-by-pretzel-isoflavone-dietary-intervention-127698https://curecurrent.com/trials/integrating-enhanced-hiv-prep-into-a-sti-clinic-in-lilongwe-127699https://curecurrent.com/trials/optimizing-counceling-on-feeding-options-of-babies-from-mothers-living-with-hiv-127700https://curecurrent.com/trials/acute-effects-of-tcig-vs-ecig-in-plwh-127701https://curecurrent.com/trials/dtg-plus-3tc-for-prophylaxis-of-mother-to-child-transmission-of-hiv-infection-in-pregnant-women-127702https://curecurrent.com/trials/alcohol-metabolic-comorbidities-in-plwha-evidence-driven-interventions-127703https://curecurrent.com/trials/increasing-statin-prescribing-in-hiv-behavioral-economics-research-127704https://curecurrent.com/trials/methadone-maintenance-and-hiv-prevention-a-window-of-opportunity-in-china-127705https://curecurrent.com/trials/effect-of-heroin-use-on-immune-activation-and-cardiovascular-risk-in-hiv-127706https://curecurrent.com/trials/assessing-differential-adherence-to-medications-and-quality-of-life-among-people-living-with-hiv-and-comorbidities-127707https://curecurrent.com/trials/effects-of-glucocorticoids-on-cognition-in-hiv-infected-women-127708https://curecurrent.com/trials/assessment-of-hiv-remission-upon-cart-interruption-in-early-treated-individuals-carrying-the-mhc-b35-53bw4ttc2-genotype-127709https://curecurrent.com/trials/aberrant-myeloid-lineage-differentiation-in-hiv-aids-patients-127710https://curecurrent.com/trials/manicaland-prep-uptake-through-interactive-counselling-trial-127711https://curecurrent.com/trials/menjaga-continuous-quality-improvement-for-antenatal-hiv-syphilis-and-hepatitis-b-testing-in-indonesia-127712https://curecurrent.com/trials/compression-therapy-for-leg-ulcers-and-kaposi-sarcoma-in-western-kenya-127713https://curecurrent.com/trials/anrs-12415-quali-prep-cambodia-127714https://curecurrent.com/trials/text-messaging-plus-motivational-interviewing-in-promotion-of-breastfeeding-among-hiv-infected-women-127715https://curecurrent.com/trials/study-of-leukocyte-interleukin-injection-for-treatment-of-perianal-warts-127716https://curecurrent.com/trials/seville-cohort-of-people-living-with-hiv-at-risk-for-anal-cancer-127717https://curecurrent.com/trials/seville-cohort-of-people-at-substantial-risk-for-hiv-infection-on-pre-exposure-prophylaxis-127718https://curecurrent.com/trials/acquired-epidermodysplasia-verruciformis-ev-syndrome-in-hiv-infected-pediatric-patients-127719https://curecurrent.com/trials/switch-strategy-from-etravirine-etr-to-doravirine-dor-in-virologically-suppressed-hiv-1-infected-adults-with-etr-resista-127720https://curecurrent.com/trials/the-influence-of-primary-hiv-1-drug-resistance-mutations-on-immune-reconstruction-in-plwh-127721https://curecurrent.com/trials/testing-of-the-integrated-rapid-access-to-hiv-prevention-program-for-people-who-inject-drugs-program-127722https://curecurrent.com/trials/a-sub-study-of-cabotegravir-cab-and-rilpivirine-rpv-in-human-immunodeficiency-viruses-hiv-infected-participants-127723https://curecurrent.com/trials/computer-training-and-transcranial-direct-current-stimulation-for-cognition-in-hiv-127724https://curecurrent.com/trials/a-test-and-treat-strategy-in-new-hiv-diagnosis-127725https://curecurrent.com/trials/a-pharmacokinetic-evaluation-of-tenofovir-emtricitabine-as-hiv-pre-exposure-prophylaxis-in-transgender-women-127726https://curecurrent.com/trials/sns-and-prep-initiation-and-adherence-in-black-smm-127727https://curecurrent.com/trials/a-study-to-assess-the-acceptability-of-the-darunavir-cobicistat-drv-cobi-fixed-dose-combination-fdc-tablet-in-human-immu-127728https://curecurrent.com/trials/immunomodulators-on-hiv-1-reservoir-127729https://curecurrent.com/trials/mobile-technology-to-extend-clinic-based-counseling-for-hiv-s-in-uganda-127730https://curecurrent.com/trials/can-undetectable-viral-load-untransmissible-virus-change-the-life-course-of-adolescents-living-in-africa-127731https://curecurrent.com/trials/uptake-of-medical-male-circumcision-among-men-with-sexually-transmitted-infections-127732https://curecurrent.com/trials/assessing-preference-for-3-female-condoms-a-comparative-evaluation-of-the-path-woman-s-condom-fc2-and-the-reddy-6-127733https://curecurrent.com/trials/women-in-dual-with-dolutegravir-127734https://curecurrent.com/trials/anti-hiv-medications-for-people-recently-infected-with-hiv-127735https://curecurrent.com/trials/artibiome-observational-study-on-the-effect-of-hiv-and-art-on-gut-microbiome-127736https://curecurrent.com/trials/effects-of-maraviroc-vs-efavirenz-on-cd4-cd8-ratio-127737https://curecurrent.com/trials/optimizing-prep-utilization-among-alcohol-and-other-drug-aod-using-women-of-color-127738https://curecurrent.com/trials/prepared-rn-can-nurse-led-management-of-high-risk-patients-for-pre-exposure-prophylaxis-prep-127739https://curecurrent.com/trials/prep-restart-for-adolescent-girls-and-young-women-using-sti-self-testing-and-assessment-of-risk-127740https://curecurrent.com/trials/feasibility-of-sbirt-pn-127741https://curecurrent.com/trials/sns-to-increase-hiv-testing-uptake-and-linkage-to-double-cascade-services-among-adolescent-msm-and-tgw-in-thailand-127742https://curecurrent.com/trials/preptech-phase-2-study-of-a-prep-telehealth-intervention-127743https://curecurrent.com/trials/prevention-of-hiv-aids-and-stds-in-women-over-fifty-127744https://curecurrent.com/trials/broadly-neutralizing-antibodies-3bnc117-ls-10-1074-ls-to-prevent-relapse-during-ati-127745https://curecurrent.com/trials/effectiveness-of-a-multifactorial-intervention-in-frailty-individuals-with-hiv-infection-hidra360-127746https://curecurrent.com/trials/gonorrhea-and-chlamydia-hiv-infected-men-who-have-sex-with-men-127747https://curecurrent.com/trials/chronic-hiv-infection-and-aging-in-neuroaids-chain-127748https://curecurrent.com/trials/impacts-of-different-art-regimens-on-lipid-metabolism-in-people-living-with-hiv-127749https://curecurrent.com/trials/incidence-and-prevalence-of-cancer-in-people-living-with-hiv-aids-at-cancer-centers-in-latin-america-127750https://curecurrent.com/trials/a-pharmacokinetic-evaluation-of-levonorgestrel-implant-and-antiretroviral-therapy-127751https://curecurrent.com/trials/aria-to-predict-coronary-artery-disease-in-hiv-infected-individuals-127752https://curecurrent.com/trials/evaluation-of-hiv-1-recent-infection-testing-in-rwanda-127753https://curecurrent.com/trials/lifestyle-modification-programme-for-hiv-infected-individuals-with-fatty-liver-127754https://curecurrent.com/trials/lubiprostone-as-a-modulator-of-gut-microbial-translocation-in-hiv-with-incomplete-cd4-recovery-on-antiretroviral-therapy-127755https://curecurrent.com/trials/hepatocellular-carcinoma-in-hiv-infected-individuals-in-asian-population-127756https://curecurrent.com/trials/clinical-outcomes-in-hiv-with-comorbidities-127757https://curecurrent.com/trials/elvucitabine-efavirenz-tenofovir-versus-lamivudine-efavirenz-tenofovir-in-human-immunodeficiency-virus-hiv-1-infected-tr-127758https://curecurrent.com/trials/frailty-in-older-hiv-infected-individuals-127759https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-immunogenicity-of-the-nonavalent-vaccine-against-human-papillomavirus-in-men-infected-b-127760https://curecurrent.com/trials/a-pragmatic-trial-with-optimized-dose-of-rifampicin-and-moxifloxacin-for-the-treatment-of-drug-susceptible-pulmonary-tub-127761https://curecurrent.com/trials/study-of-once-daily-elvucitabine-versus-lamivudine-in-participants-with-a-documented-m184v-mutation-127762https://curecurrent.com/trials/probiotics-and-influenza-vaccination-response-127763https://curecurrent.com/trials/the-lymphoid-tissue-pharmacology-of-antiretroviral-drugs-127764https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-comparing-dolutegravir-plus-lamivudine-with-dolutegravir-plus-tenofovir-emtric-127765https://curecurrent.com/trials/the-effectiveness-of-skill-based-hiv-psychoeducation-in-iv-drug-abuser-for-reducing-high-risk-behavior-127766https://curecurrent.com/trials/improving-pregnancy-outcomes-with-preventive-therapy-in-africa-2-improve-2-127767https://curecurrent.com/trials/partners-based-hiv-treatment-for-couples-attending-antenatal-care-127768https://curecurrent.com/trials/impact-of-ccr5-blockade-in-hiv-kidney-transplant-recipients-127769https://curecurrent.com/trials/hiv-infected-latin-american-asylum-seekers-in-europe-insights-from-the-eurolatin-hiv-cohort-127770https://curecurrent.com/trials/antiretroviral-adherence-and-drug-level-monitoring-127771https://curecurrent.com/trials/whole-food-plant-based-diet-for-hiv-associated-reduction-in-cardiovascular-risk-plant-hart-127772https://curecurrent.com/trials/assess-therapeutic-efficacy-and-emergence-of-hiv-drug-resistance-following-initiation-of-tld-127773https://curecurrent.com/trials/obstructive-sleep-apnea-endotypes-and-impact-on-phenotypes-of-people-living-with-hiv-127774https://curecurrent.com/trials/cancer-treatment-decision-making-in-the-hiv-population-an-observational-study-of-physician-patient-interactions-127775https://curecurrent.com/trials/experimental-analysis-of-hiv-risk-assessment-reactivity-in-south-african-clinics-127776https://curecurrent.com/trials/adherence-toolkit-for-managing-nonadherence-to-hiv-medications-in-indonesia-127777https://curecurrent.com/trials/leveraging-electronic-health-record-data-in-a-risk-prediction-model-to-increase-hiv-prep-intake-in-primary-care-127778https://curecurrent.com/trials/impaact-1077hs-examining-benefits-of-haart-continuation-in-postpartum-women-127779https://curecurrent.com/trials/treatment-with-lorcaserin-for-cocaine-use-the-tlc-study-127780https://curecurrent.com/trials/mindfulness-and-acceptance-based-therapy-for-adolescents-living-with-hiv-127781https://curecurrent.com/trials/adaptation-of-the-friendship-bench-intervention-for-hiv-infected-perinatal-women-in-lilongwe-127782https://curecurrent.com/trials/open-label-48-week-extension-study-of-elvucitabine-in-combination-with-background-antiretroviral-therapy-art-for-partici-127783https://curecurrent.com/trials/an-open-label-treatment-protocol-to-provide-continued-elvucitabine-treatment-127784https://curecurrent.com/trials/functional-cure-of-hepatitis-b-in-hiv-hbv-co-infected-patients-127785https://curecurrent.com/trials/the-evaluation-of-anti-interference-ability-and-clinical-specificity-of-hiv-ag-ab-assay-kit-sysmex-127786https://curecurrent.com/trials/safety-and-drug-detection-study-of-dapivirine-vaginal-ring-and-oral-truvada-in-breastfeeding-mother-infant-pairs-127787https://curecurrent.com/trials/a-hiv-vaccine-trial-in-individuals-who-started-antiretrovirals-during-primary-or-chronic-infection-ehva-t02-127788https://curecurrent.com/trials/rct-of-an-internet-cessation-program-plus-online-social-network-for-hiv-smokers-127789https://curecurrent.com/trials/evaluation-of-genexpert-hiv-1-as-the-gold-standard-test-for-hiv-1-viral-load-count-127790https://curecurrent.com/trials/microeconomic-intervention-to-reduce-hiv-transmission-in-economically-disadvantaged-transgender-women-127791https://curecurrent.com/trials/dora-a-doravirine-based-first-line-antiretroviral-therapy-for-women-of-reproductive-potential-living-with-hiv-127792https://curecurrent.com/trials/inter-cohorts-and-clinical-centres-collaborations-of-subjects-co-infected-with-hiv-and-hcv-127793https://curecurrent.com/trials/like-father-like-son-127794https://curecurrent.com/trials/the-value-of-hpv-testing-for-cervical-cancer-screening-in-women-living-with-hiv-papillo-vih-127795https://curecurrent.com/trials/condom-use-attitudes-beliefs-and-behaviors-127796https://curecurrent.com/trials/confidential-social-network-referrals-for-hiv-testing-127797https://curecurrent.com/trials/online-hiv-prevention-for-young-male-couples-127798https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-of-mva-hti-and-chadox1-hti-with-vesatolimod-in-hiv-1-positive-patients-127799https://curecurrent.com/trials/mobile-evidence-based-smoking-cessation-for-veterans-living-with-hiv-mesh-127800https://curecurrent.com/trials/investigating-the-interaction-between-two-long-acting-reversible-methods-of-contraception-and-dolutegravir-a-treatment-f-127801https://curecurrent.com/trials/vitamin-e-for-nash-treatment-in-hiv-infected-individuals-127802https://curecurrent.com/trials/adherence-to-antiretroviral-therapy-in-hiv-infected-individuals-in-assiut-governorate-egypt-127803https://curecurrent.com/trials/switch-study-to-evaluate-dolutegravir-plus-lamivudine-in-virologically-suppressed-human-immunodeficiency-virus-type-1-po-127804https://curecurrent.com/trials/driveshaft-darunavir-ritonavir-in-hiv-infected-virologically-suppressed-experienced-subjects-127805https://curecurrent.com/trials/zadaxin-and-hiv-positive-patients-with-immune-reconstitution-disorder-127806https://curecurrent.com/trials/y2prevent-preventing-drug-use-and-hiv-through-empowerment-social-support-and-mentorship-y2p-127807https://curecurrent.com/trials/vgx-3100-delivered-intramuscularly-im-followed-by-electroporation-ep-for-the-treatment-of-hpv-16-and-or-hpv-18-related-a-127808https://curecurrent.com/trials/tms-for-smoking-cessation-in-plwha-cessation-in-people-living-with-hiv-aids-plwha-127809https://curecurrent.com/trials/packaging-prep-to-prevent-hiv-among-wwid-127810https://curecurrent.com/trials/multi-component-intervention-to-improve-health-outcomes-and-quality-of-life-among-rural-older-adults-living-with-hiv-127811https://curecurrent.com/trials/qualitative-understanding-of-community-tb-services-pre-and-post-the-chip-tb-trial-127812https://curecurrent.com/trials/early-community-client-led-art-delivery-in-nakivale-refugee-settlement-127813https://curecurrent.com/trials/exercise-therapy-with-telerehabilitation-in-patients-living-with-hiv-127814https://curecurrent.com/trials/effects-of-e-cigarettes-ecigs-on-pulmonary-inflammation-and-behavior-in-hiv-infected-smokers-127815https://curecurrent.com/trials/sexual-needs-of-adolescents-living-with-hiv-since-childhood-127816https://curecurrent.com/trials/bringing-south-african-men-into-hiv-counseling-and-testing-and-care-127817https://curecurrent.com/trials/prep-it-mobile-app-intervention-127818https://curecurrent.com/trials/a-pragmatic-trial-of-two-strategies-for-implementing-an-effective-ehealth-hiv-prevention-program-keep-it-up-3-0-127819https://curecurrent.com/trials/identifying-efficient-linkage-strategies-for-men-127820https://curecurrent.com/trials/griffithsin-based-rectal-microbicide-for-prevention-of-viral-entry-prevent-127821https://curecurrent.com/trials/pilot-peg-interferon-a2b-in-decreasing-viral-dna-in-hiv-127822https://curecurrent.com/trials/healing-hearts-and-mending-minds-in-older-adults-living-with-hiv-127823https://curecurrent.com/trials/pneumocystis-jirovecii-pneumonia-in-non-hiv-infected-immunocompromised-patients-127824https://curecurrent.com/trials/acceptability-safety-and-use-of-daily-truvada-pre-exposure-prophylaxis-in-adolescents-127825https://curecurrent.com/trials/s1204-viral-screening-in-newly-diagnosed-cancer-patients-127826https://curecurrent.com/trials/connecting-youth-and-young-adults-to-optimize-art-adherence-youthrive-efficacy-trial-127827https://curecurrent.com/trials/posse-project-a-community-level-intervention-for-black-ymsm-127828https://curecurrent.com/trials/boston-arch-4f-intervention-to-reduce-fall-risk-in-people-with-hiv-and-alcohol-use-127829https://curecurrent.com/trials/safety-and-efficacy-study-of-kl-7shrna-injection-solution-in-the-treatment-of-aids-patients-with-lymphoma-127830https://curecurrent.com/trials/seroprevalence-of-monkeypox-infection-among-people-living-with-hiv-and-prep-users-127831https://curecurrent.com/trials/alcohol-monitor-validation-127832https://curecurrent.com/trials/the-pharmacokinetics-safety-and-tolerability-of-abacavir-dolutegravir-lamivudine-dispersible-and-immediate-release-table-127833https://curecurrent.com/trials/addressing-health-disparities-in-engagement-retention-and-utilization-of-prep-among-south-florida-women-of-color-127834https://curecurrent.com/trials/3bnc117-ls-and-10-1074-ls-in-viremic-hiv-infected-individuals-127835https://curecurrent.com/trials/innovative-strategies-to-increase-art-initiation-and-viral-suppression-among-hiv-positive-men-in-malawi-127836https://curecurrent.com/trials/forging-sustainable-solutions-for-hiv-continuity-of-care-through-medical-legal-partnerships-127837https://curecurrent.com/trials/evaluating-the-safety-of-and-adherence-to-a-vaginal-matrix-ring-containing-dapivirine-and-oral-emtricitabine-tenofovir-d-127838https://curecurrent.com/trials/efficacy-of-vhm-after-treatment-interruption-in-subjects-initiating-art-during-acute-hiv-infection-127839https://curecurrent.com/trials/adapting-a-behavioral-intervention-to-accommodate-cognitive-dysfunction-in-people-who-inject-drugs-127840https://curecurrent.com/trials/we-prevent-a-dyadic-approach-to-hiv-prevention-and-care-among-young-male-couples-127841https://curecurrent.com/trials/hiv-reengagement-and-assessment-mobile-program-project-ramp-127842https://curecurrent.com/trials/hiv-resilience-qualitative-study-hong-kong-127843https://curecurrent.com/trials/efficacy-and-safety-study-of-pegylated-interferon-lambda-1a-with-ribavirin-and-daclatasvir-to-treat-na-ve-subjects-with-127844https://curecurrent.com/trials/a-study-of-the-gut-barrier-and-blood-vessel-inflammation-in-individuals-with-and-without-hiv-127845https://curecurrent.com/trials/providing-suboxone-and-prep-using-telemedicine-127846https://curecurrent.com/trials/enhancing-partner-services-among-men-who-have-sex-with-men-living-with-hiv-127847https://curecurrent.com/trials/study-of-entry-and-continuation-in-care-for-people-living-with-hiv-in-french-guiana-127848https://curecurrent.com/trials/kenya-enhanced-mentor-mother-program-emma-127849https://curecurrent.com/trials/safety-and-immunogenicity-of-v114-in-children-infected-with-human-immunodeficiency-virus-hiv-v114-030-pneu-way-ped-127850https://curecurrent.com/trials/epidemiology-of-hepatitis-b-c-and-d-and-hiv-along-the-maroni-river-bordering-french-guiana-and-suriname-mahevi-127851https://curecurrent.com/trials/a-technology-delivered-peer-to-peer-support-art-adherence-intervention-for-substance-using-hiv-adults-127852https://curecurrent.com/trials/boston-alcohol-research-collaboration-on-hiv-aids-arch-cohort-the-4f-study-127853https://curecurrent.com/trials/effects-of-eplerenone-on-cardiovascular-disease-in-hiv-miracle-hiv-study-127854https://curecurrent.com/trials/a-food-effect-study-of-the-pediatric-dispersible-tablet-formulations-of-triumeq-and-dovato-in-healthy-adult-participants-127855https://curecurrent.com/trials/testing-an-online-intervention-to-improve-parents-communication-with-gay-and-bisexual-sons-about-sex-and-hiv-127856https://curecurrent.com/trials/neuropsychological-outcomes-of-internationally-adopted-children-who-are-perinatally-infected-with-human-immunodeficiency-127857https://curecurrent.com/trials/evaluation-of-the-population-level-impact-of-pmtct-option-b-in-zimbabwe-127858https://curecurrent.com/trials/therapeutic-vaccination-in-treated-hiv-disease-127859https://curecurrent.com/trials/monitoring-pre-exposure-prophylaxis-for-young-adult-women-127860https://curecurrent.com/trials/project-soar-mental-health-malawi-depression-and-hiv-integration-127861https://curecurrent.com/trials/intervention-to-facilitate-mmt-hiv-service-decentralization-in-vietnam-127862https://curecurrent.com/trials/a-mobile-intervention-to-promote-cessation-in-hiv-infected-smokers-127863https://curecurrent.com/trials/anxiety-sensitivity-treatment-for-heroin-users-127864https://curecurrent.com/trials/immune-reconstitution-of-lopinavir-ritonavir-based-vs-efavirenz-based-haart-in-advanced-hiv-disease-127865https://curecurrent.com/trials/the-bshape-intervention-program-for-safety-and-health-of-survivors-of-cumulative-trauma-127866https://curecurrent.com/trials/pharmacokinetics-of-calcineurin-mtor-inhibitors-in-hiv-1-infected-kidney-transplant-recipients-after-switch-to-bic-ftc-t-127867https://curecurrent.com/trials/smoking-cessation-in-a-cohort-hiv-rio-de-janeiro-brazil-127868https://curecurrent.com/trials/allyquest-adherence-app-intervention-for-hiv-positive-men-who-have-sex-with-men-and-transgender-women-pilot-trial-127869https://curecurrent.com/trials/evaluating-the-safety-and-antiviral-activity-of-monoclonal-antibody-vrc01-in-infants-with-hiv-receiving-combination-anti-127870https://curecurrent.com/trials/mesenchymal-stem-cells-for-immune-non-responder-patients-with-hiv-infection-127871https://curecurrent.com/trials/dolutegravir-in-real-life-in-lesotho-127872https://curecurrent.com/trials/combo-pep-multipurpose-prevention-of-post-exposure-prophylaxis-regimens-127873https://curecurrent.com/trials/awareness-of-osteoporosis-in-hiv-patients-127874https://curecurrent.com/trials/combining-tlr9-agonist-with-bnabs-for-reservoir-reduction-and-immunological-control-of-hiv-127875https://curecurrent.com/trials/hiv-jail-poc-agab-testings-127876https://curecurrent.com/trials/cardiovascular-disease-in-hiv-and-hepatitis-c-risk-outcomes-after-hepatitis-c-eradication-127877https://curecurrent.com/trials/assessment-of-bronchial-obstruction-in-adolescents-with-hiv-127878https://curecurrent.com/trials/study-to-evaluate-safety-and-toxicity-of-polyphenon-e-egcg-in-hiv-1-infected-individuals-127879https://curecurrent.com/trials/immune-response-to-seasonal-influenza-vaccine-in-hiv-infected-individuals-127880https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-a-prophylactic-hiv-vaccine-candidate-127881https://curecurrent.com/trials/syphilis-and-hiv-point-of-care-testing-poct-in-saskatchewan-127882https://curecurrent.com/trials/hbv-hiv-coinfection-research-network-127883https://curecurrent.com/trials/mwach-prep-a-sms-based-support-intervention-to-enhance-prep-adherence-during-pregnancy-and-breastfeeding-127884https://curecurrent.com/trials/project-smart-automated-pillbox-study-127885https://curecurrent.com/trials/support-to-reunite-involve-and-value-each-other-127886https://curecurrent.com/trials/engaging-men-through-hiv-self-testing-with-differentiated-care-to-improve-art-initiation-and-viral-suppression-among-men-127887https://curecurrent.com/trials/expectation-motivation-and-experience-of-hiv-patients-regarding-participation-to-an-hiv-cure-related-clinical-trial-127888https://curecurrent.com/trials/covid-19-and-hiv-patients-127889https://curecurrent.com/trials/study-to-evaluate-effects-of-vorinostat-and-hxtc-on-persistent-hiv-1-infection-in-hiv-infected-subjects-started-on-antir-127890https://curecurrent.com/trials/the-positively-dance-pilot-program-for-women-living-with-hiv-127891https://curecurrent.com/trials/vedolizumab-treatment-in-antiretroviral-drug-treated-chronic-hiv-infection-127892https://curecurrent.com/trials/a-proof-of-concept-study-to-evaluate-the-effect-of-ub-421-in-combination-with-chidamide-on-hiv-viral-reservoir-127893https://curecurrent.com/trials/optimising-cohorts-for-hiv-cure-interventions-127894https://curecurrent.com/trials/early-art-initiation-among-hiv-positive-pregnant-women-in-central-mozambique-127895https://curecurrent.com/trials/pharmacokinetics-of-atazanavir-in-special-populations-127896https://curecurrent.com/trials/working-with-hiv-clinics-to-adopt-addiction-treatments-using-implementation-facilitation-127897https://curecurrent.com/trials/keeping-it-lite-exploring-hiv-risk-in-vulnerable-youth-with-limited-interaction-and-digital-health-intervention-127898https://curecurrent.com/trials/reducing-hiv-vulnerability-through-a-multilevel-life-skills-intervention-for-adolescent-men-127899https://curecurrent.com/trials/emtricitabine-tenofovir-alafenamide-switch-study-for-transgender-individuals-for-hiv-pre-exposure-prophylaxis-127900https://curecurrent.com/trials/australian-hepatitis-and-risk-survey-in-prisons-127901https://curecurrent.com/trials/integrated-treatment-for-smoking-cessation-anxiety-in-people-with-hiv-127902https://curecurrent.com/trials/sexual-health-impact-of-using-pre-exposure-hiv-prophylaxis-127903https://curecurrent.com/trials/effect-of-a-psychological-intervention-on-antiretroviral-therapy-and-mental-health-outcomes-in-hiv-positive-adults-in-zi-127904https://curecurrent.com/trials/infant-tb-infection-prevention-study-127905https://curecurrent.com/trials/sleep-disorders-and-psychophysical-well-being-in-hiv-patients-127906https://curecurrent.com/trials/providing-prep-hepatitis-c-treatment-and-moud-through-telemedicine-at-greensboro-ssp-127907https://curecurrent.com/trials/phase-ii-study-of-dose-adjusted-epoch-rituximab-in-adults-with-untreated-burkitt-lymphoma-and-c-myc-diffuse-large-b-cell-127908https://curecurrent.com/trials/empiric-treatment-for-acute-hiv-in-the-ed-127909https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-three-different-dna-hiv-vaccines-administered-with-a-mva-cmdr-boost-vaccine-127910https://curecurrent.com/trials/the-impact-evaluation-of-the-covid-19-prevention-on-risk-factors-of-hiv-and-sexually-transmitted-comorbidity-127911https://curecurrent.com/trials/suppression-of-hiv-1-rna-in-people-living-with-hiv-127912https://curecurrent.com/trials/phat-life-peer-versus-adult-led-hiv-prevention-for-juvenile-offenders-127913https://curecurrent.com/trials/a-48-week-observational-study-of-the-frequency-of-symptomatic-herpes-virus-i-and-ii-in-hiv-infected-subjects-127914https://curecurrent.com/trials/amsterdam-umc-clinical-trial-with-a-native-like-hiv-1-envelope-vaccine-127915https://curecurrent.com/trials/prize-linked-savings-initiatives-for-promoting-better-health-and-economic-outcomes-in-kenya-127916https://curecurrent.com/trials/rapid-diagnostics-for-hiv-and-hepatitis-127917https://curecurrent.com/trials/trauma-informed-intervention-to-support-engagement-in-hiv-care-among-msm-thrive-127918https://curecurrent.com/trials/effect-of-il-1-inhibition-on-inflammation-and-cardiovascular-risk-127919https://curecurrent.com/trials/development-of-a-tailored-smoking-cessation-program-for-individuals-with-hiv-infection-in-washington-d-c-127920https://curecurrent.com/trials/french-cac-hiv-cohort-study-127921https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-a-heterologous-prime-boost-vaccine-regimen-of-ad26-mos4-hiv-and-aluminum-phosphate-adj-127922https://curecurrent.com/trials/linking-infectious-and-narcology-care-part-ii-127923https://curecurrent.com/trials/dolutegravir-and-darunavir-evaluation-in-adults-failing-therapy-127924https://curecurrent.com/trials/the-safety-and-effectiveness-of-different-doses-of-vitamin-c-in-hiv-infected-patients-127925https://curecurrent.com/trials/evaluating-the-safety-and-pharmacokinetics-of-pc-1005-administered-rectally-to-hiv-1-seronegative-adults-127926https://curecurrent.com/trials/study-to-identify-and-determine-best-implementation-practices-for-injectable-cabotegravir-rilpivirine-in-the-united-stat-127927https://curecurrent.com/trials/treatment-substitution-with-pro-140-monotherapy-in-adult-subjects-with-hiv-1-infection-127928https://curecurrent.com/trials/acceptability-of-human-papillomavirus-self-sampling-in-women-living-with-hiv-127929https://curecurrent.com/trials/quantification-of-estradiol-s-impact-on-nucleotides-in-cellular-populations-of-the-lower-gi-tract-127930https://curecurrent.com/trials/id-testing-in-male-partners-127931https://curecurrent.com/trials/study-to-evaluate-the-safety-of-a-gene-and-cell-therapy-product-in-participants-with-hiv-that-is-well-controlled-on-anti-127932https://curecurrent.com/trials/evaluation-of-safety-tolerability-pharmacokinetics-and-antiretroviral-activity-of-ulonivirine-mk-8507-in-human-immunodef-127933https://curecurrent.com/trials/community-influences-transitions-in-youth-health-city-health-ii-center-for-the-study-of-community-health-127934https://curecurrent.com/trials/exploring-a-digital-hiv-onward-disclosure-intervention-in-people-living-with-hiv-of-sub-saharan-african-ethnicity-127935https://curecurrent.com/trials/search-for-fragility-indicators-among-people-aged-50-with-chronic-hiv-infection-127936https://curecurrent.com/trials/the-swissprepared-study-127937https://curecurrent.com/trials/study-on-the-prevalence-of-hepatitis-c-in-a-psychiatric-population-127938https://curecurrent.com/trials/a-registry-study-on-hiv-related-lymphoma-127939https://curecurrent.com/trials/e-smart-est-hiv-telehealth-intervention-127940https://curecurrent.com/trials/evaluating-the-safety-and-serum-concentrations-of-a-human-monoclonal-antibody-vrc-hivmab075-00-ab-vrc07-523ls-administer-127941https://curecurrent.com/trials/linking-women-to-prep-care-127942https://curecurrent.com/trials/mhealth-facilitated-intervention-to-improve-hiv-pre-exposure-prophylaxis-adherence-127943https://curecurrent.com/trials/mhealth-facilitated-intervention-to-improve-medication-adherence-among-persons-living-with-hiv-127944https://curecurrent.com/trials/effects-of-cannabidiol-cbd-on-the-activation-of-autophagy-and-inflammation-genes-functional-consequences-in-virologicall-127945https://curecurrent.com/trials/evaluating-an-innovative-hiv-self-testing-service-with-counseling-provided-by-a-chatbot-127946https://curecurrent.com/trials/a-safety-pharmacokinetics-and-pharmacodynamics-study-of-abx464-in-hiv-1-seronegative-and-seropositive-adults-127947https://curecurrent.com/trials/safety-and-efficacy-of-t8-on-treating-chronic-abnormal-immune-activation-in-hiv-aids-patients-127948https://curecurrent.com/trials/providing-unique-support-for-health-push-study-127949https://curecurrent.com/trials/heplisav-b-revaccination-for-hepatitis-b-vaccine-nonresponders-127950https://curecurrent.com/trials/a-pilot-intervention-to-improve-coping-with-discrimination-and-adherence-among-hiv-positive-latino-msm-127951https://curecurrent.com/trials/vicente-ferrer-hiv-cohort-study-127952https://curecurrent.com/trials/islatravir-mk-8591-with-doravirine-and-lamivudine-in-participants-infected-with-human-immunodeficiency-virus-type-1-mk-8-127953https://curecurrent.com/trials/therapeutic-vaccine-based-on-adc1-dendritic-cells-for-the-control-of-viremia-after-ati-in-hiv-infected-individuals-127954https://curecurrent.com/trials/improving-identification-of-social-harm-among-substance-abusers-in-hiv-trials-127955https://curecurrent.com/trials/clinical-monitoring-to-facilitate-continuous-care-for-substance-abusing-clients-127956https://curecurrent.com/trials/reducing-high-risk-behavior-in-treatment-court-127957https://curecurrent.com/trials/mk-8510-monotherapy-for-the-treatment-of-anti-retroviral-na-ve-human-immunodeficiency-virus-type-1-hiv-1-infected-partic-127958https://curecurrent.com/trials/the-effect-tenofovir-disoproxil-fumarate-tdf-and-tenofovir-alafenamide-taf-on-small-intestine-gut-wall-127959https://curecurrent.com/trials/clinical-decision-support-reminders-to-improve-ipt-initiation-among-hiv-positive-adults-in-western-kenya-127960https://curecurrent.com/trials/the-dtg-switch-study-longitudinal-analysis-of-virologic-failure-and-drug-resistance-at-and-after-switching-to-dolutegrav-127961https://curecurrent.com/trials/stigma-social-support-and-quality-of-life-127962https://curecurrent.com/trials/safety-and-efficacy-of-high-dose-rifampicin-in-tuberculosis-tb-hiv-co-infected-patients-on-efavirenz-or-dolutegravir-bas-127963https://curecurrent.com/trials/family-connection-pilot-of-family-based-self-management-for-hiv-infected-adolescents-127964https://curecurrent.com/trials/immunogenicity-of-novel-h1n1-vaccination-among-hiv-infected-compared-to-hiv-uninfected-persons-127965https://curecurrent.com/trials/life-steps-for-prep-for-youth-127966https://curecurrent.com/trials/coronary-artery-disease-and-its-association-with-liver-steatosis-among-hiv-infected-persons-127967https://curecurrent.com/trials/pet-imaging-of-the-dopaminergic-and-serotonergic-systems-in-treated-hiv-positive-subjects-127968https://curecurrent.com/trials/arterial-elasticity-a-substudy-of-strategic-timing-of-antiretroviral-treatment-start-127969https://curecurrent.com/trials/resistance-testing-to-improve-management-of-virologic-failure-in-sub-saharan-africa-127970https://curecurrent.com/trials/change-the-cycle-an-rct-to-prevent-injection-initiation-127971https://curecurrent.com/trials/interaction-between-hiv-and-platelets-127972https://curecurrent.com/trials/friends-for-life-circles-for-option-b-plus-127973https://curecurrent.com/trials/a-study-to-evaluate-safety-and-immunogenicity-of-a-covid-19-vaccine-in-people-living-with-hiv-at-risk-for-sars-cov-2-cov-127974https://curecurrent.com/trials/valproic-acid-and-its-effects-on-hiv-latent-reservoirs-127975https://curecurrent.com/trials/safety-and-tolerability-of-pro-140-in-hiv-uninfected-male-volunteers-127976https://curecurrent.com/trials/metformin-immunotherapy-in-hiv-infection-127977https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-alvac-hiv-and-mf59-or-as01b-adjuvanted-bivalent-subtype-c-gp120-in-healthy-h-127978https://curecurrent.com/trials/selection-of-farnesoid-x-receptor-fxr-ligands-on-the-reactivation-of-latent-hiv-proviruses-127979https://curecurrent.com/trials/comparative-efficacy-and-safety-study-of-dolutegravir-and-lopinavir-ritonavir-in-second-line-treatment-127980https://curecurrent.com/trials/effects-of-covid-19-on-endothelium-in-hiv-positive-patients-in-sub-saharan-africa-127981https://curecurrent.com/trials/a-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-abbv-181-budigalimab-in-adult-participants-with-127982https://curecurrent.com/trials/clinical-outcomes-of-people-who-acquired-hiv-in-early-life-127983https://curecurrent.com/trials/analysis-of-oxidative-stress-biomarkers-and-their-determinants-in-art-experienced-plwh-127984https://curecurrent.com/trials/10e8-4-imab-bispecific-antibody-in-hiv-uninfected-and-hiv-infected-adults-127985https://curecurrent.com/trials/the-effects-of-exercise-training-in-vascular-function-of-patients-living-with-hiv-127986https://curecurrent.com/trials/promoting-reductions-in-intersectional-stigma-prism-ghana-127987https://curecurrent.com/trials/increasing-prep-with-trans-women-in-the-deep-south-127988https://curecurrent.com/trials/tough-talks-a-disclosure-intervention-for-hiv-young-men-who-have-sex-with-men-ymsm-127989https://curecurrent.com/trials/prospective-study-of-methicillin-resistant-staphylococcus-aureus-mrsa-among-hiv-infected-persons-127990https://curecurrent.com/trials/perspective-memory-and-executive-functions-in-hiv-patients-127991https://curecurrent.com/trials/pregnancy-and-neonatal-outcomes-following-antenatal-exposure-to-raltegravir-a-pooled-analysis-from-the-european-pregnanc-127992https://curecurrent.com/trials/feasibility-and-impact-of-online-hiv-sti-screening-addressed-to-prep-users-in-spain-127993https://curecurrent.com/trials/analysis-of-the-persistence-reservoir-and-hiv-latency-127994https://curecurrent.com/trials/impaact-p1107-effects-of-cord-blood-transplantation-with-ccr5-32-donor-cells-on-hiv-persistence-127995https://curecurrent.com/trials/a-study-to-learn-about-the-medicine-called-nirmatrelvir-used-in-combination-with-ritonavir-in-people-with-weakened-immun-127996https://curecurrent.com/trials/hiv-prevention-among-latina-transgender-women-who-have-sex-with-men-evaluation-of-a-locally-developed-intervention-127997https://curecurrent.com/trials/vir-1111-a-prototype-human-cmv-based-vaccine-for-human-immunodeficiency-virus-hiv-in-healthy-volunteers-127998https://curecurrent.com/trials/smoking-cessation-pilot-for-people-living-with-hiv-plwh-127999https://curecurrent.com/trials/a-pragmatic-clinical-trial-of-mypeeps-mobile-to-improve-hiv-prevention-behaviors-in-diverse-adolescent-msm-128000https://curecurrent.com/trials/ad26-zebov-booster-in-hiv-adults-previously-vaccinated-with-ad26-zebov-mva-bn-filo-ebovac-hiv-booster-study-128001https://curecurrent.com/trials/a-clinical-study-of-the-hiv-drug-cpt31-in-healthy-volunteers-128002https://curecurrent.com/trials/2nd-ac-new-village-model-128003https://curecurrent.com/trials/study-to-evaluate-the-feasibility-of-community-based-test-and-treat-strategies-among-men-who-have-sex-with-men-and-trans-128004https://curecurrent.com/trials/gardasil-immunogenicity-with-needle-free-injection-128005https://curecurrent.com/trials/evaluation-of-a-facility-based-test-treat-and-prevent-hiv-program-among-men-who-have-sex-with-men-and-transgender-women-128006https://curecurrent.com/trials/the-role-of-diet-education-and-nutritional-counselling-in-the-ongoing-care-of-people-living-with-hiv-in-thailand-128007https://curecurrent.com/trials/writing-to-alleviate-violence-exposure-for-transgender-women-wave-tw-128008